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A standard zebrafish toxicological test, DarT (Danio rerio Teratogenic 
assay), is based on wild-type zebrafish embryo and it has been widely used for 
toxicological screenings. With the availability of many fluorescent transgenic 
zebrafish strains to have their organs and tissues specifically labeled by 
fluorescent proteins, we envision that the fluorescent markers may provide 
more sensitive and convenient endpoints for monitoring chemical induced 
phenotypical changes. In this project, we selected nine transgenic zebrafish 
lines to investigate their suitability for testing chemicals with different 
categories of toxicity. For most of these tested fluorescent strains, we found 
marked improvement in sensitivity. We also identified three transgenic lines for 
developing specific toxicity assays: including neurotoxicity assay using 
Tg(nkx2.2a:mEGFP), hepatotoxicity assay using 
Tg(fabp10a:DsRed;elaA:EGFP), and inflammation assay using 
Tg(lysC:DsRed2). Thus, our study may open a new avenue to use other 
fluorescent transgenic zebrafish to develop sensitive and specific toxicological 
tests for different categories of chemicals. 
For neurotoxicity assay, we employed Tg(nkx2.2a:mEGFP) transgenic 
zebrafish which have GFP expression in the central nervous system to 
investigate its potential for screening neurotoxic chemicals. Five potential 
neurotoxins (acetaminophen, atenolol, atrazine, ethanol and lindane) and one 
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neuroprotectant (mefenamic acid) were tested. We found that the GFP-labeled 
ventral axons from trunk motoneurons, which were easily observed in live fry 
and measured for quantification, were highly sensitive to all of the five 
neurotoxins and the length of axons was significantly reduced in fry which 
looked normal based on DarT endpoints at low concentrations of neurotoxins. 
Compared to the most sensitive endpoints of DarT, ventral axon marker could 
improve the detection limit of these neurotoxins by about 10 fold. Thus, 
ventral axon lengths provide a convenient and measureable marker 
specifically for neurotoxins.  
For hepatotoxicity assay, since red fluorescence in the liver greatly 
facilitates the observation of liver in live LiPan fry, we first tested four 
well-established hepatotoxins (acetaminophen, aspirin, isoniazid and 
phenylbutazone) in LiPan fry and demonstrated that these hepatotoxins could 
significantly reduce both liver red fluorescence and liver size in a 
dosage-dependent manner, thus the two measurable parameters could be used 
as indicators of hepatotoxicity. We then tested the LiPan fry with nine other 
chemicals including environmental toxicants and human drugs. Three 
(mefenamic acid, lindane, and arsenate) behave like hepatotoxins in reduction 
of liver red fluorescence, while three others (17b-estradiol, TCDD 
[2,3,7,8-tetrachlorodibenzo-p-dioxin] and NDMA [N-nitrosodimethylamine]) 
caused increase of liver red fluorescence and the liver size. Ethanol and two 
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other chemicals, amoxicillin (antibiotics) and chlorphenamine (pain killer) did 
not resulted in significant changes of liver red fluorescence and liver size. By 
quantitative RT-PCR analysis, we found that the changes of red fluorescence 
intensity caused by different chemicals correlated to the changes of 
endogenous fabp10a RNA expression, indicating that the measured 
hepatotoxicity was related to fatty acid transportation and metabolism. These 
results suggest that the transgenic zebrafish assay is capable of reporting 
compound hepatotoxicity effect from chemical mixtures. 
For inflammation assay, we totally tested 12 chemicals by using 
Tg(lysC:DsRed2) fry, which has RFP labeled neutrophils. We use the software 
Imaris to count the number of neutrophil. We found that most of the 
environmental toxicants can cause inflammation reaction with increasing 
number of neutrophils. Therefore, this transgenic line might be useful for rapid 
inflammation assay. 
Other than these, we also performed real water sample tests, which 
indicating that the fluorescent transgenic zebrafish could be useful for testing 
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1.1 General toxicology 
Toxicology is the study of adverse effects of chemicals on living organisms 
including human. Many different factors influence chemical toxicity, including 
chemical dosage or concentration, route of exposure, toxin species, surrounding 
environment and individual characteristics of the living organisms. These 
factors interact with each other and lead to toxicity response/effect on living 
organisms. Different organisms may have different responses to the same 
toxicity condition, as well as different tolerance for the same chemical. 
Therefore the test for safe dose of each chemical on human and other organisms 
is of crucial importance.  
Toxicological tests have a close relationship with food safety and drug safety 
in human life. Food safety is threatened by chemical contamination and 
pathogens. For example, algal toxins frequently cause acute diseases and fungal 
toxins may also not only be acutely toxic but also have chronic sequelae 
(Borchers et al., 2010). Perhaps more worrisome, the rapidly expanding 
industrial activities of the last century have resulted in massive increases in our 
exposure to toxic chemicals, many of which are now present in the food chain 
and exhibit various toxicities. Some of these toxic chemicals, although banned a 
long time ago, remain persistent in the environment including our food chain 
(Borchers et al., 2010). 
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For drug safety test, on one hand, researchers need to find the minimum 
effective dose to treat diseases, as a high dose may cause metabolism disorder or 
tissue injury in human body. On the other hand, they also need to find the 
minimum lethal dose, under which death of experimental animal (e.g. rat, 
mouse, rabbit) is caused. For example, LC50, under which concentration the 
mortality rate of treated animals is 50%, is frequently used for toxicity 
evaluation. For human safety, the maximum dose can be applied to human must 
be below the LC50 of experimental animals (e.g. mouse, rat, and rabbit) 
(Devillers and Devillers, 2009). 
Almost all the toxicity tests for chemicals follow the classic dose response 
curve, i.e. with the increasing dosage of toxins, there is an increasing mortality 
rate on testing organisms. This is important for testing not just environmental 
toxicants such as herbicides and insecticide, but also for human drugs. For 
instance, when we test human antibiotics, we would like to kill bacteria; 
however, when the dose is too high, it might be harmful to our bodies, so we 
should determine a safe dose to use, which helps to kill most of the bacteria and 
at the same time, has little side effects on human.  
1.1.1 Environmental toxicology 
Environmental toxicology deals with toxicants in our surroundings that are 
harmful to health (causing distress or diseases), such as air pollutants and 
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aquatic pollutants. Nowadays, there is an increasing attention to air pollution 
and aquatic pollution, as they have close relevance to our daily life. To breath 
clean air and to drink healthy water are fundamental aspects of human life.  
There are neumerous categories of environmental toxicants, including 
pesticides (insecticides, herbicides, fungicides and rodenticides), PPCPs 
(pharmaceuticals and personal care products), EDCs (endocrine disrupting 
chemicals), POPs (persistent organic pollutants), metals, HABs (harmful algal 
blooms), and many others. There are tremendous attention to risk assessment of 
different environmental toxicants. WHO (World Health Organization) and EPA 
(US Environmental Protection Agency) have stipulated a series of guidelines 
for different chemicals (Boethling et al., 2009; CVMP/VICH, 2000; 
EMEA/CHMP, 2006).  
1.1.1.1 Air pollution 
Air pollution concerns chemicals, particulates and biological materials which 
are released into atmosphere and cause discomfort, diseases or death to human 
or other organisms. Some common air pollutants, such as SOx, NOx, CO, and 
others, like volatile organic compounds, particulates, toxic metals, CFCs 
(chlorofluorocarbon), radioactive pollutants and ground level ozone are all 




There are mainly two sources for air pollution: man-made sources (e.g. 
manufacturing facilities, motor vehicles, dust and controlled burn practices in 
agriculture and forest management, etc, ) and natural sources (e.g. gas released 
from digestion of food by animals, smoke from wildfire, and volcanic activity). 
To protect human from air pollutions, control for the indoor air quality is 
necessary, as formulated in the WHO and EPA guidelines as standards for good 
air quality (Augusto et al., 2013; Nielsen et al., 2013; Umweltbundesamtes, 
2013). 
Air pollutions could lead to bad health effects, such as asthma, cardiovascular 
health, cystic fibrosis and lung cancer. Therefore, it is crucial to reduce the air 
pollutants through different ways, such as control of technologies, regulation of 
man-made sources and legal regulation. 
1.1.1.2 Aquatic pollution 
Aquatic pollution is water contamination, including contaminations in lakes, 
rivers, oceans, aquifers and ground water etc. Pollutants could be directly or 
indirectly discharged into water. Water contamination may have seriously 
adverse effects and affects aquatic organisms as well as human through drinking 
water, food chain and water activities (Calderon, 2000; Li, 2014; Perez Perez, 
2001). 
There are mainly two sources of aquatic pollution: point sources and 
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nonpoint sources. A point source refers to contaminants that enter a waterway 
from a single, identifiable source, such as a pipe or ditch. A nonpoint source 
refers to diffuse contamination that does not originate from a single discrete 
source. Furthermore, there are also many different pollutants: pathogens, 
organic compounds, inorganic compounds, macroscopic pollution and thermal 
pollution, etc. 
Water contaminations could be transported by flow of water and have chains 
of chemical reactions which may finally lead to serious effect harmful to human. 
Therefore, it is of importance to measure the level of contamination through 
sampling, physical testing, chemical testing and biological testing. Meanwhile, 
proper control of domestic sewerage, industrial wastewater, agricultural 
wastewater and stormwater plays an important role in control of water 
contamination. 
For both OCED and US EPA guide line, or other international standard 
aquatic toxicity tests (EPA, 2011; Escher and Hermens, 2002; OECD, 2006), 
all of them cover several different categories, including freshwater, marine 
water and sediment environments. There are mainly two kind of standardized 
tests: acute test (24–96 hours) and chronic toxicity tests (7 days or more). These 
tests measure many different endpoints of aquatic organisms, such as survival 
rate, developmental delay and reproduction ability. These endpoints are 
measured at different concentrations in gradient along with control group.  
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Aquatic organisms, particularly fish, have been popularly used in aqutic 
toxicological tests and there are basically two types of tests, acute and chronic. 
In acute tests, which are short-term exposure tests (hours or days) and generally 
use lethality (i.e. LC50 or LC30) as an endpoint. In acute exposures, depending 
on absorption time of the toxicant, organisms come into contact with high doses 
of the toxicant usually produce immediate effects. These tests are generally 
conducted on organisms during a specific time period of the organism’s life 
cycle, and are considered partial life cycle tests (McKim et al., 1987). Chronic 
tests, which are long-term tests (weeks, months or years), generally use 
sub-lethal endpoints. In chronic exposures, organisms come into contact with 
low, continuous doses of a toxicant. The results are generally reported as 
NOECs (no observed effects concentration) and LOECs (lowest observed 
effects level) (Weltje et al., 2013). In addition, early life stage tests, which are 
considered as subchronic exposures that are less than a complete reproductive 
life cycle, mainly include exposure during early, sensitive life stages of an 
organism, such as embryo-larval, or egg-fry tests (Barahona and 
Sanchez-Fortun, 1996). 
 For all of these test methods, lethality is the most common endpoint used in 
toxicology, particularly for acute toxicity tests. In chronic toxicity tests, 
sublethal endpoints should be considered, such as abnormality of morphology, 
developmental delay, change of behavioral/physiological manners. In addition, 
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histological changes may also be examined, e.g. some carcinogens may cause 
increasing of cell proliferation, and the nuclei might become larger and the cell 
shape may be irregular (McHugh Law et al., 1998). 
1.1.2 Mode of toxicity 
Mode of toxicity is physiological and behavioral signs that characterize a 
type of adverse biological response. Based on toxic action, there are two major 
types of toxicants: non-specific acting toxicants and specific acting toxicants. 
For non-specific acting toxicants, they may result in narcosis, i.e. general 
depression in biological activity. Specific acting toxicant have different specific 
effects on biological activities, such as uncoupling of oxidative 
phosphoxylation, acetylcholinesterase (AChE) inhibition, irritantion, CNS 
(central nervous system) seizure and respiratory blocking (Escher et al., 2011; 
Escher and Hermens, 2002). 
For determination of the mode of toxicity in fish, EPA has formulated a 
guideline known as Fish Acute Toxicity Syndrome (FATS), which is to assess 
the behavioral and physiological responses of the fish in toxicity tests, 
including locomotive activities, body color, ventilation patterns, cough rate, 
heart rate, and others (Escher and Hermens, 2002).  
There are also other methods to evaluate toxicity, such as critical body 
residues (CBR), which is the whole-body concentration of a chemical that is 
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associated with a given adverse biological response and it is estimated using 
a partition coefficient and a bioconcentration factor (Barron et al., 2002). In 
other words, CBR is the concentration of chemical bio-accumulated in an 
aquatic organism that corresponds to a defined measure of toxicity (e.g. 
mortality). CBR can provide an alternative measure of toxicity to traditional 
waterborne concentration measurements (e.g. concentration in water causing 50% 
mortality) (Barron et al., 1997). The whole-body residues are 
reasonable approximations of the amount of chemical present at the toxic action 
site(s) (Barron et al., 2002; McCarty LS, 1993).  
1.1.2.2 Neurotoxicity 
Neurotoxicity refers adverse effects on nervous system, which lead to 
damage to nervous tissues or system. Neurotoxicity could be caused by 
chemotherapy, radiation treatment, drug therapy, drug abuse, and heavy metal 
exposure etc (Lu et al., 2003; Rothenberg and Ellisen, 2012). 
The term neurotoxicity is generally used to describe a condition or substance 
that has been shown to result in observable physical damage to the nervous 
system. In some cases the level or exposure-time may be critical, with some 
substances only becoming neurotoxic in certain doses or time periods. When 
neurotoxins are present at high concentrations, they can lead to neurotoxicity 
and neuron apoptosis. Some of the symptoms resulting from neuron death 
include loss of motor control, cognitive deterioration and autonomic nervous 
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system dysfunction (Tilson, 2000). Additionally, neurotoxicity has been found 
to be a major cause of neurodegenerative diseases such as Alzheimer's disease. 
Neurotoxic effects can be observed at various levels of the organization of the 
nervous system, including neurochemical, anatomical, physiological, or 
behavioral. At the neurochemical level, for example, an agent that causes 
neurotoxicity might inhibit macromolecule or transmitter synthesis, alter the 
flow of ions across cellular membranes, or prevent release of neurotransmitter 
from the nerve terminals. Anatomical changes may include alterations of the 
cell body, the axon, or the myelin sheath. At the physiological level, a chemical 
might change the thresholds for neural activation or reduce the speed of 
neurotransmission. Behavioral alterations can include significant changes in 
sensations of sight, hearing and/or touch; alterations in simple or complex 
reflexes and motor functions; alterations in cognitive functions such as learning, 
memory, or attention; and changes in mood, such as fear or rage, disorientation 
as to person, time, or place, or distortions of thinking and feeling, such as 
delusions and hallucinations. (Tilson, 2000) 
1.1.2.3 Hepatotoxicity 
Hepatotoxicity is chemical-driven liver injuries/damages or liver functional 
disorders. Hepatotoxins are toxic chemicals that damage the liver and cause 
liver functional disorders. Some hepatotoxins are relevant to environmental 
contamination while others may be related to pharmaceutical uses. 
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Hapatotoxins have a variety of mechanisms causing liver damages leading to 
different grades of liver conditions such as zonal necrosis, hepatitis, cholestasis, 
steatosis, granuloma and even neoplasm (Sumeet Dwivedi, 2008; Zimmerman, 
1993; Zimmerman, 1999). 
As the liver is the most important organ in drug metabolism, one of the major 
causes of drug attrition during the pre-approval and post-approval stages of the 
drug development and marketing process is drug-induced liver injury (Hill et al., 
2012a). Thus, it is crucially important to develop rapid and convenient 
approaches not only for monitoring environmental contaminants but also for 
detection potential hepatotoxicity in drug candidates screening. 
There are also many in vitro and in vivo models for hepatotoxin tests in drug 
development process. For in vitro study, human HepG2 cells have been 
popularly used with a capability of developing to high-throughput, high-content 
assays for screening a broad range of compounds (O'Brien et al., 2006; Tolosa et 
al., 2013). Current technology is based on immortalized cell lines such as rodent 
cells and primary human hepatocytes, all of which suffer from their inherent 
weakness. In vitro rodent cells have limited relevance to human physiology, and 
primary human cells remain a scarce and variable resource. Thus, these systems 
are inadequate, as evident from the high levels of compound attrition in the 
clinical trial and postmarketing stages, causing safety concerns and high 
financial costs.  
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 In recent years, there are also pluripotent stem cell-derived hepatocyte-like 
cells to serve as an additional method of testing hepatotoxicity in the drug 
development progress (Greenhough and Hay, 2012). The advantage of using 
stem cells is that they are capable of renewing themselves and cultured in an 
undifferentiated state, giving rise to more specialized cells of under a defined 
condition. In any process where adult human hepatocytes are currently utilized, 
including toxicology and drug metabolism studies and even in the cell therapy 
of liver diseases, these stem cells could be useful. The use of stem cell–derived 
in vitro models will overcome costly and labor-intensive toxicology studies 
performed in primary cellular reagents or in vivo animal models. Therefore, 
stem cells are an important new tool for developing unique, in vitro model 
systems to test drugs and chemicals and have a potential to predict or anticipate 
toxicity in humans (Davila et al., 2004). Meanwhile, increased understanding of 
pluripotency, differentiation and reprogramming, combined with optimization 
of tissue culture environments, will allow the ongoing issues of hepatocyte 
lifespan and immature function to be addressed. 
In addition to measurement of activities of conventional liver enzymes such 
as GGT (gamma-glutamyltransferase), ALT (alanine aminotransferase) and 
AST (aspartate aminotransferase) (Niemela and Alatalo, 2010), now different 
types of hepatotoxins could be distinguished by different biomarkers; for 
example, a PCR array-based assay is available to analyze the expression of 84 
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key genes implicated as potential biomarkers of liver toxicity (Kasap et al., 
2012), including the following functional categories: cell proliferation (e.g. 
aurora kinase A, B, C), DNA methylation (e.g. DNA-methyltransferase 1, 3a, 
3b), histone modification (e.g. histone deacetylase 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11), chromatin remodeling and transcriptional regulation (e.g. lysine-specific 
demethylase 4A, 4C, 5C, 6B) etc.  
In sum, both in vitro and in vivo hepatotoxicity assays have been well 
established. However, the in vitro assays lack the physiological context as in 
the whole organisms while in vivo animal models such as mice is generally 
costly and it requires a long time to complete the test. Therefore, a more 
economical in vivo animal model such as the zebrafish will be highly 
appreciated in hepatotoxicity test.  
1.2 Zebrafish as a model for toxicity tests 
1.2.1 Fish as models in aquatic toxicology 
In the last three decades, the alarming dispersion of contaminants in the 
terrestrial environment originated a profuse quantity of laboratory-based 
behavioural studies in mammals, mainly rodents (Germolec et al., 2012; Lee et 
al., 2012). Nowadays, along with increase and presence of toxicants in aquatic 
ecosystems, there should be a priority that the laboratory-based rodent 
analyses are rapidly complemented by fish models. Fish represent the largest 
14 
 
and most diverse group of vertebrates. A number of other characteristics make 
them excellent experimental models for studies in embryology, neurobiology, 
endocrinology, environmental biology, and other areas. Fish might be much 
more vulnerable than higher vertebrates to environmental changes, which can 
markedly affect their metabolic and behavioural pathways (Manciocco et al., 
2014).  
Many fish species have been used for aquatic toxicology researches, such 
as fathead minnow, rainbow trout, brook trout, bluegill sunfish, goldfish, guppy, 
Japanese medaka, and zebrafish (Belanger et al., 2013; Braunbeck et al., 1992; 
Hermens et al., 1984; Santore et al., 2002). Many chemical catenaries have 
been tested with these fish models in the past several decades, including a lot 
of organic or inorganic compounds, and metals (Defo et al., 2014; MacDougal 
et al., 1996; Pacitti et al., 2013).  
The use of quantitative structure activity relationship (QSAR) models as 
rapid and predictive screening tools to select more potentially hazardous 
chemicals for in-depth laboratory evaluation had been applied for many years 
(Moore et al., 2003). QSAR models are regression or classification models used 
in the chemical and biological sciences and engineering. Like other regression 
models, QSAR regression models relate a set of "predictor" variables (X) to the 
potency of the response variable (Y), while classification QSAR models relate 
the predictor variables to a categorical value of the response variable. A QSAR 
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has the form of a mathematical model: Activity = f (physicochemical properties 
and/or structure properties) + Error (Delgado et al., 2012). For example, 
biological activity can be expressed quantitatively as the concentration of a 
substance required to give a certain biological response. Additionally, when 
physicochemical properties or structures are expressed by numbers, one can 
find a mathematical relationship, or quantitative structure-activity relationship, 
between the two (de Haas et al., 2011; Nantasenamat et al., 2010).  
The development of fish acute toxicity syndromes (FATS), which are toxic- 
response sets based on various behavioral and physiological-biochemical 
measurements are important endpoints for aquatic toxicity measurement 
(Claeys et al., 2013; Levet et al., 2013). For example, using behavioral 
parameters monitored in the fathead minnow during acute toxicity testing, 
FATS associated with acetyl-cholin- esterase (AChE) inhibitors and narcotics 
could be reliably predicted. Moreover, by using respiratory-cardiovascular 
responses in the rainbow trout, it enabled FATS associated with AChE 
inhibitors, convulsants, narcotics, respiratory blockers, respiratory membrane 
irritants, and uncouplers to be correctly predicted (Belanger et al., 2013; 
McKim et al., 1987).  
In the last two decades, small aquarium fish such as zebrafish and medaka 
have been used as good models for aquatic toxicology and carcinogenesis 
research (Bailey et al., 1996; Bunton, 1996). Medaka and zebrafish can be 
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easily raised side by side in one aquatic system because they both require the 
same conditions with respect to water quality, temperature and light cycle. 
Most of the standard experimental procedures can be applied to both species 
with slight modifications, including the observation of embryos, gynogenesis, 
sperm freezing, in vitro fertilization, cell transplantation, RNA and DNA 
injection, in situ hybridization and immune-histochemistry. Methods for the 
production of transgenic fish by injection of DNA constructs, transposon or 
viral vectors are well established for both species. The use of Green 
Fluorescent Protein (GFP) reporters allows comparative in vivo studies of gene 
expression. Morpholino-based knock-down experiments have also been 
successfully applied in both species. The primary strength of zebrafish and 
medaka systems is their usefulness for developmental biological studies. With 
advantages of the medaka and zebrafish, they are opening gate for many 
aspects of biological researches, especially aquatic toxicology research 
(Furutani-Seiki and Wittbrodt, 2004). 
Aquatic toxicology research mainly focus on the following categories of 
toxicants: pharmaceuticals and personal care products (PPCPs), endocrine 
disrupting chemicals (EDCs), persistent organic compounds (POPs), 
organo-nitrogen compound, and metalloid compound. Table 1.1 shows the 
applications of wild-type zebrafish for environmental monitoring. For example, 
the most common method of monitoring toxic heavy metals is toxicity 
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experiments with both embryos and adult zebrafish. Some heavy metals can 
inhibit the activity of enzymes or affect genes expression (Richetti et al., 2011; 
Wu et al., 2012). For endocrine disruptors, they can affect the synthesis, release, 
transport, metabolism, and combination of endocrine substances, thereby 
leading to reproductive problems, birth defects, developmental abnormalities, 
metabolic disorders, and cancer. (Dai et al., 2014).  
 
Table 1.1 Applications of wild-type zebrafish for environmental monitoring 






1.2.2 Zebrafish toxicological assays: DarT and MolDarT  
The zebrafish (Danio rerio) has been an increasingly popular experimental 
model in biological research in the past two decades, not only in developmental 
biology but also in biomedical research. It is also a preferable in vivo model 
when compared with cell-based in vitro systems as it provides valuable 
information in a physiological context. The zebrafish model has many 
advantages in laboratory research, e.g. transparent embryos, high fecundity 
with hundreds of embryos from each single spawning on a daily basis, low cost 
and space requirement for aquarium maintenance, etc. Furthermore, as a 
vertebrate model, the zebrafish offers more relevant information to human 
health than invertebrate models such as Drosophila and Caenorhabditis elegans 
(Lieschke and Currie, 2007). 
 In the past decade or so, the value of the zebrafish model has also been 
increasingly recognized in toxicology and environmental science (Hill et al., 
2005). An intense effort has advanced the zebrafish as a model for the genetic 
and genomic study of vertebrate development, and has led to the emergence of 
this organism as a major platform for the annotation of gene function. More 
recently, investigators have begun to use high-throughput approaches in the 
zebrafish for disease modeling and for chemical biology, combining these in 
drug discovery screens (Peterson and Macrae, 2012). 
In 2002, Nagal has described a standard DarT (Danio rerio Teratogenic 
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assay), in which wild-type zebrafish embryos are used to monitor several lethal 
and sublethal endpoints for evaluating the potential toxicity of chemicals at 
different developmental stages, and the assay covers essentially all major 
organs and systems in zebrafish (Nagel, 2002a). Since then, it has been an 
established zebrafish embryo test recommended by OECD (Organisation for 
Economic Co-operation and Development) and it is also widely used in 
chemical screening (McGrath and Li, 2008).  
It is well known that fish are the most widely used vertebrate for 
environmental risk assessment (Bopp SK, 2006). The use of fish for acute 
toxicity tests of chemicals, biocides (e.g. pesticides, herbicides and fungicides) 
and pharmaceuticals for environmental risk assessment and routine tests of 
waste water effluents are required by legislation in European and other 
industrialized countries (CVMP/VICH, 2000; EMEA/CHMP, 2006; OSPAR, 
2000). Among the several small fish species recommended for standard tests 
of chemicals and environmental samples, the zebrafish has been the most 
popular and best studied model (Bopp SK, 2006; Nagel, 2002a; Scholz et al., 
2008). Zebrafish embryos are being used for acute toxicity tests for effluent as 
required by the German Wastewater Charges Act (Gazette, 2005). Within 
OECD, test guidelines for endocrine-disruptive chemicals include the 
zebrafish embryos as one of the principal tests (OECD, 2006). It is anticipated 
that fish embryo test for chemical safety will be incorporated into many 
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international water quality guidelines (Scholz et al., 2008). 
Table 1.2, summarizing several lethal and sub-lethal endpoints used in DarT, 
covering the survival rate, tail detachment rate, normal somite rate, heartbeat, 
blood circulation and edema rate etc. As inferred from the DarT assay, the 
zebrafish would be very convenient for high-throughput screening of toxicants, 
for that zebrafish embryos/larvae could be observed under microscope in a 
microtiter plate (i.e. 6-, 12-, 24- or 96-well) with a small quantity (i.e., mg/L, 




Table 1.2 DarT endpoints 
 




However, for wild-type embryos and fry, the morphological changes may not 
always be obvious, particularly in some internal organs (e.g. liver, pancreas, 
kidney, etc.). MolDarT is another proposed toxicological test based on zebrafish 
embryos (Muncke et al., 2007) and it analyzes mRNA abundance of selected 
biomarker RNAs after chemical exposure. Some molecular markers have been 
verified as biomarkers for MolDarT endpoints, such as metallothionein 2 (mt2), 
cytochrome P450 1A1 (cyp1a1), and recombination activation gene 1 (rag1). 
The mt2 gene is inducible by metal exposure and has been shown to respond 
strongly to heavy metals, especially to Hg (Guerrero-Castilla et al., 2014; Wu et 
al., 2012). Cyp1a1 mono-oxigenase is inducible by ligand-activated aromatic 
hydrocarbon receptor (AhR) such as TCDD (Jenny et al., 2009). Rag1 is 
a recombination-activating gene and encodes an enzyme that plays an 
important role in the rearrangement and recombination of the genes 
of immunoglobulin and T cell receptor molecules during the process of VDJ 
recombination, and it is crucial for acquired immunity. Rag1 marks chemicals 
which associated with immune response, such as heavy metal or other immune 
response-related chemicals (Um et al., 2013).  
MolDarT provides an effective test system which allows multiple effect 
detection in a single-exposure sample through assessment of RNA expression 
of multiple biomarker genes. Thus, MolDarT is another potentially useful 
approach for toxicological tests, but more biomarker genes are needed and 
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validated in order to improve the applicability of MolDarT. Now there are 
more biomarkers for different specific categories of toxins. For example, for 
hepatotoxins, lactate dehydrogenase (LDH) and glutamate dehydrogenase 
(GDH) are good markers (Przybylak and Cronin, 2012). 
In recent years, many potencial biomarkers for different chemical 
categories have been found by microarray and RNA-Seq data analyse. These 
genomic tools not only provide a valuable complement to existing 
ecotoxicologic methods used in evaluating environmental contamination, but 
also allow the identification of novel biomarkers for specific contaminants 
and aid in the development of new assays aimed at identifying adverse effects 
(Denslow et al., 2007).  
For example, our laboratory has carried out RNA-seq analysis of hepatic 
response of zebrafish to several environmental chemicals, including arsenic 
(Xu et al., 2013), TCDD (Li et al., 2013), and sex hormone (Zheng et al., 
2013). In an RNA-Seq analyses of arsenic exposed zebrafish, 27 out of 29 
up-regulated transcripts identified by RNA-Seq were validated by RT-qPCR 
analysis. Among these, 14 transcripts were further confirmed for 
up-regulation by a lower dosage of arsenic in majority of individual zebrafish. 
Finally, at least four of these genes, frh3 (ferrintin H3), mgst1 (microsomal 
glutathione S-transferase-like), cmbl (carboxymethylene- butenolidase 
homolog) and slc40a1 (solute carrier family 40 [iron-regulated transporter], 
24 
 
member 1) were confirmed in individual medaka fish to be up-regulated by 
arsenic; thus, these four genes might be robust arsenic biomarkers across fish 
species (Xu et al., 2013). For perturbation by TCDD, which induces AhR 
pathway, an RNA-Seq based transcriptomic profiling revealed a total of 1,058 
significantly differently expressed genes based on fold-change 2 and TPM 
(transcripts per million) 10. Among the top 20 up-regulated genes, 10 were 
novel responsive genes and they were further verified by RT-qPCR analysis 
with independent and individual samples. (Li et al., 2013). 
However, for MolDarT, there are still some shortcomings, e.g. technical 
complexity, and a long assay time for RNA extraction, reverse transcription 
and real time RT-PCR. Therefore, MolDarT might not be as convenient as 
traditional DarT, which is based on easily observable endpoints. 
1.2.3 Application of transgenic fish to environmental monitoring and 
toxicology 
Fluorescent transgenic zebrafish with a tissue-specific promoter to target a 
living color reporter gene (i.e. GFP and RFP) to a specific tissue/organ have 
been popularly used in developmental biology (Gong et al., 2001; Udvadia 
and Linney, 2003a). Moreover, fluorescent transgenic fish have also been 
generated as a predictive tool for assessing drug-induced toxicity, including 
cardiotoxicity, hepatotoxicity, neutotoxicity and developmental toxicity by 
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using specific inducible promoters and living color reporter gene fusions 
(Carvan et al., 2007; Ng et al., 2011; Peterson and Macrae, 2012; Sipes et al., 
2011; Teraoka et al., 2003). Similarly, these properties should be applied for 
biomonitoring of water contamination due to their convenience and 
observable changes of fluorescent appearance (Ng et al., 2011).  
For instance, estrogenic compounds are a major category of aquatic 
pollutants (Matozzo et al., 2008) and the main molecular marker vitellogenin 
(vtg) mRNA could be induced by exogenous 17β-estradiol in both zebrafish 
and medaka (Tong et al., 2004). Tg(vtg1:GFP) transgenic medaka line was 
engineered by using the vtg promoter to drive GFP expression in order to 
monitoring 17β-estradiol (Zeng et al., 2005). Similarly, for heavy metals, 
several transgenic zebrafish lines had been generated, such as Tg(hsp70: GFP) 
and Tg(hsp27:GFP) (Blechinger et al., 2002a; Blechinger et al., 2002b; Wu et 
al., 2008). For POPs (persistent organic pollutants) like TCDD, AhR 
responsive Tg(cyp1a:EGFP) medaka and zebrafish have been created (Kim et 
al., 2013; Ng and Gong, 2013), which could detect as low as 0.005 nM TCDD. 
For other toxicity test, like neurotoxicity, a medaka line expressing green 
fluorescent protein (GFP) under the control of the zebrafish neurogenin 1 
(ngn1) gene promoter was created for rapid developmental neurotoxicity 
screening (Fan et al., 2011). For endocrine disrupting chemicals, a transgenic 
zebrafish line Tg(cyp19a1b-GFP) was generated, which expresses the green 
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fluorescent protein (GFP) under the control of the cyp19a1b (brain aromatase 
or aromatase B) gene to determine the estrogenic potency of ER (estrogen 
receptor) agonists alone or in mixtures (Petersen et al., 2013). Another 
transgenic zebrafish line Tg(TSHβ:EGFP) was created to serve as a rapid in 
vivo model for assessing thyroid-disrupting chemicals, as thyroid-stimulating 
hormone subunit β (TSHβ) plays central regulatory roles in the 
hypothalamic–pituitary–thyroid (HPT) system, and a wide range of chemicals 
have the ability to interfere with the HPT, such as potassium perchlorate 
(KClO4), 6-propyl-2-thiouracil (PTuracil), triiodothyronine (T3) and 
thyroxine (T4) (Ji et al., 2012). 
There are several advantages to use living color transgenic fish as tools for 
biomonitoring of aquatic contamination. First, it does not need the sacrifice of 
organisms and allow continuous observation. Second, in vivo tests in fish 
compared to in vitro assays, provide more relevant information about 
chemical toxicity in a physiological context. Third, these technologies could 
detect the combined effect of chemical mixture, which do not need the 
characterization of each single chemical. Fourth, as a potential online 
monitoring system in real environment, the use of transgenic fish monitoring 
technology can serve as an early and sensitive indicator of potential problems. 
Finally, zebrafish can be maintained at a quite low cost compared with most if 
not all other model organisms (Ng et al., 2011). 
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1.3 Rationale of the study 
Even though zebrafish embryos have been increasingly used for screening 
of toxicants for more than 10 years, there are still several limitations as 
discussed in the previous section. For example, DarT is based on wild-type 
embryos/fry; it is difficult to analyze internal organs/tissue and the assay may 
not be very sensitive to low concentrations of toxicants. MolDarT is not so 
convenient in practice and its protocol is time-consuming and requires 
sophisticated equipment.  
Since late 1990s, GFP/RFP and other fluorescent protein transgenic 
zebrafish have played an important role in developmental analyses as the 
fluorescence-labeled tissues and organs can be conveniently monitored in live 
embryos/larvae throughout the early development (Gong et al., 2001; Udvadia 
and Linney, 2003b). Now a large number of fluorescent transgenic zebrafish 
lines including enhancer/gene-trapped lines are available. As exampled in 
Fig.1.1, these transgenic zebrafish lines have been engineered for 
tissue-specific fluorescent protein expression in essentially all tissues and 
organs, e.g. Tg(nkx2.2a:mEGFP) with GFP expression in the central nervous 
system (Ng et al., 2005), Tg(ﬂi1:EGFP) with GFP in blood vessels (Lawson 
and Weinstein, 2002), Tg (lfabf:DsRed; elaA:EGFP) (the LiPan) with liver 
RFP and pancreas GFP (Korzh et al., 2008a), Tg(krt8:EGFP) with GFP in skin 
epithelia (Gong et al., 2002) etc. Since GFP/RFP expression has provided an 
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excellent opportunity for observation of more detailed teratogenic changes, we 
envisage that the fluorescence-labeled tissues/organs may be more sensitive 
markers than wild-type embryos/fry in toxicological and teratogenic tests. 
Thus, with the application of fluorescent transgenic zebrafiah embryos/fry in 
toxicological tests, we hope to establish new and improved toxicity assays 
tentatively termed as FT-DarT for fluorescent transgenic DarT, for screening 





Fig.1.1 Available fluorescent transgenic zebrafish lines. A.Tg(mylz2: 
EGFP)/Tg(mylz2:DsRed). B. LiPan: Tg (lfabf:DsRed; elaA:EGFP). C. 
Tg(nkx2.2a: mEGFP). D. Tg(krt8:EGFP). E. Tg(ﬂi1:EGFP). F. Tg (ins:gfp). G. 





1.4 Hypothesis, Objectives and scope of study 
The main hypothesis of the current study is that: fluorescent transgenic 
embryos/fry may provide more sensitive and specific tools than wild-type 
embryos/fry in toxicological test. By taking advantages of the availability of 
various fluorescent transgenic zebrafish lines for developmental analysis in our 
laboratory, this project aims at developing new and more sensitive assays for 
monitoring water contamination and for evaluating health effects of water 
contaminants. 
Our specific aims include:  
 Screening of selected fluorescent transgenic lines for suitable FT-DarT 
(fluorescent transgenic-DarT) approaches. 
 Selection of promising transgenic lines for developing specific toxicity 
assays: i.e., Tg(nkx2.2a: GFP) for neurotoxicity assay, the LiPan for 
hepatotoxicity assay and Tg(lysC:DsRed2) for inflammation response. 
 Application of the novel assays established in this project to evaluate 
authentic environmental samples such as sewerage water and production 













2. Materials and methods 
2.1 Transgenic zebrafishe lines for FT-Dart 
Nine fluorescent transgenic zebrafish lines were chosen for chemical 
screening by FT-DarT in this project. Their names, tissues of transgene 




Table 2.1. Summary of fluorescent transgenic zebrafish lines used in this study 




EGFP expression in the brain, ventral 
neural tube, developing pancreas, and a 




2 Tg(ﬂi1:EGFP) EGFP expression in all blood vessels 





3 Tg(krt8:EGFP) the surface layer of stratiﬁed epithelial 
tissues, including skin epidermis and 




4 Tg(krt8: EGFP ; 
mylz2: dsRed) 
GFP expression in the skin and RFP 
expression in fast skeletal muscles 
(Wan et 
al., 2002) 
5 LiPan:  
Tg (lfabf:DsRed; 
elaA:EGFP) 
liver-specific RFP expression and exocrine 




6 Tg (ins:gfp) GFP expression in insulin-producing cells 










EGFP expression in the mantle cells of 
neuromasts of the lateral line, branchial 
arches, tendons, a subset of interneurons in 
the dorsal spinal cord, pronephros and 
olfactory pits.  
(Choo et 
al., 2006) 








2.2 Selection of toxicant chemicals  
This project was supported by the Singapore National Research 
Foundation, under its Environmental & Water Technologies Strategic Research 
Programme and administered by the Environment & Water Industry 
Programme Office (EWI) of the PUB, grant number R-154-000-328-272.  
The toxicants tested in this projects are mainly commen enviromental 
polluents around the whole world. According to our original grant proposal, 
some compounds relevant to Singapore environment and/or of public health 
interest, including pharmaceuticals & personal care products (PPCPs), 
endocrine disrupting compounds (EDCs), persistent organic compounds 
(POPs) and compounds of emerging concern, were selected based on inputs 
from both local and international experts in PUB-CAWT, NIEHS (US GOVT), 
US EPA (US GOVT), etc.  
The list of tested chemicals is summarized in Table 2.2, covering all 
important categories of environmental chemicals and pharmaceuticals that 
may be present in water. 24 chemicals tested in the present study were 




Table 2.2. Summary of tested chemicals in this study 









Acetaminophen (Sigma, A7085) 
Chlorophenamine/ 
chlorpheniramine (Sigma, C3025)  
Amoxicillin (Sigma, 10039) 
Ponstan/ mefenamic acid 
Atenolol (Sigma, A7655) 
Aspirin (Sigma, A2093) 
Isoniazid (Fluka, I3377) 
Phenylbutazone (Sigma, P8386) 
Most commonly prescribed 












(POPs)      
 
Estradiol /17β-estradiol (Sigma, 
E8875) 
Bisphenol-A (BPA) (Sigma, 
239658) 




oxin (TCDD) (Sigma, 48599) 
Contaminants that have 
been reported to be present 
in water due to intentional 
or accidental disposal; 
leaching from plastic 








(NDMA) (Sigma, N0756) 
N-Nitrosodiethylamine (NDEA) 
(Sigma, 73861) 
4-Nitrophenol (Fluka, 1048) 
By-product of chlorination 
or disinfection in drinking 
water (for future 







arsenate heptahydrate (Sigma, 
A6756) 
Zinc/zinc sulfate heptahydrate 
( Sigma, Z0251) 
Copper/copper(II) sulfate 
(Sigma, 451657) 







chloride (Sigma, 200050) 
Erosion of natural deposits; 
runoff from orchards, runoff 
from glass & electronics 
production wastes; endemic 





Ethanol (Merck, 1.00983.2500) 
 
 
Commonly in daily life: 




2.3 DarT and FT-DarT: Treatments of the transgenic embryos  
For each fluorescent transgenic zebrafish line, we examined specific GFP / 
RFP expression in all chemical-treated embryos from 3 to 120 hpf. In addition, 
we also examined all the endpoints based on the DarT protocol (Table 1.2). 
2.3.1 Chemicals stock solution preparation  
Most of chemicals in Table 2.2 were dissolved or diluted in dimethyl 
sulfoxide (DMSO) except that zinc sulfate heptahydrate, copper(II) sulfate, 
lead(II) chloride, cadmium(II) acetate, chromium(III) chloride, mercury(II) 
chloride and sodium hydrogen arsenate heptahydrate were dissolved in MiliQ 
water directly. For every chemical, 10,000x concentrated stocks for all working 
concentrations were prepared. This was to ensure that each final concentration 
of chemical exposure would have the same amount of vehicle solvent. However, 
as sodium arsenate has low solubility in water, the stock solutions of sodium 
arsenate were 100x concentrated instead. All chemical stock solutions were 
kept at -20℃ and in dark.  
2.3.2 Fish spawning and exposure of chemical treatment to zebrafish 
embryos 
Homozygous transgenic zebrafishfish were used to cross with wild-type 
fish in order to obtain 100% transgenic embryos for chemical exposure 
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experiments. Embryos were collected and incubated in egg water (60 mg/L sea 
salt, Red Sea company) at 28°C. At ~3 hpf, the well developing and healthy 
embryos were selected for chemical exposure, which was carried out in 6-well 
plates from 3 hpf to 120 hpf. In each well, 50 embryos were placed with 10 ml 
of chemical solution. Each concentration was tested in parallel in different wells 
with four replicates. The chemical concentration ranges were determined in 
preliminary experiments with reference to previous publications if available. 
Most of the highest concentrations used for these chemicals were below LC50 
except that lindane and mefenamic acid where their highest concentration 
caused mortalities slightly higher than 50%. During the test, egg water with 
fresh chemicals solutions were replenished every day.  
2.3.3 Phenotypical observation  
During the treatment from 3 hpf to 120 hpf (before the feeding stage), several 
lethal or sublethal endpoints based on the DarT protocol (Nagel, 2002a), 
including survival rates, hatching rate, edema, tail detachment, somite 
formation, spontaneous movement, heart beat, pigmentation and touch response 
were observed and recorded as indicators for chemical toxicity. There is 
generally no significant abnormality observed in the low range of 




2.3.4 Imaging and data analysis 
Swimming larvae were anaesthetized with 0.1% 2-phenoxyethanol prior to 
photography. To position a embryo or fry for image capture, it was pipetted into 
3% methyl cellulose on a petri dish with minimal amount of water. The embryo 
and fry was observed under an inverted fluorescence microscope (Axiovert 
200M, Zeiss) equipped with a digital camera (Axiocam HRc, Zeiss) for 
capturing GFP/RFP expression.  
For direct comparison in the same set of experiment, images were taken for 
the same exposure time with a fixed aperture. At least 8-10 embryos/larvae 
were randomly selected from each dosage group for photographing.  
For each chemical concentration, there were four replicates and each 
replicate had 50 embryos. Thus, 200 embryos per chemical per dose were used. 
The number of embryos for each lethal or sublethal endpoint was recorded and 
all values were computed based on the original embryo number (n=200). 
P-value was calculated by t-test among the four replicates in comparison to 
respective controls. P<0.01 was considered highly significant difference and 




2.4 RT-qPCR (reverse transcription - quantitative polymerase chain 
reaction) 
2.4.1 RNA extraction  
Embryos or larvae were pooled together in an eppendorf tube and excess 
medium was removed. For later processing, the tubes were then rapidly frozen 
in liquid nitrogen before storage at -80°C. Sample was homogenized in 300 μl 
of TRIzol reagent (Invitrogen, USA) using a power homogenizer before 
addition of remaining 700 μl of TRIzol. The homogenized tissue was 
incubated at room temperature for 5 minutes to allow complete dissociation of 
nucleoprotein complexes. Each tube was added with 0.2 ml of chloroform and 
shaken vigorously for 15 seconds. Following incubation at room temperature 
for 3 minutes, samples were centrifuged at 12,000 x g for 15 minutes at 4 °C 
to allow the mixture to separate into a lower phenol-chloroform phase, an 
interphase and an upper aqueous phase. As RNA remains exclusively in the 
aqueous phase, this layer was transferred into a fresh eppendorf tube and RNA 
was precipitated by addition of 0.5 ml of isopropyl alcohol. After incubation at 
room temperature for 10 minutes, RNA precipitant was collected by 
centrifugation at 12,000 x g for 10 minutes and washed with 1 ml of 75% 
ethanol. To re-collect the pellet, the tube was centrifuged at 7,500 x g for 5 
minutes at 4 °C. Pellet was then air-dried for no more than 10 minutes, before 
being dissolved in diethyl pyrocarbonate (DEPC)-treated water. RNA 
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concentration was then measured by Nanodrop 2000 (Thermo Fisher 
Scientific, USA). Integrity of the RNA was evaluated with RNA gel 
electrophoresis and UV spectrophotometry. A260/A280 ratio of 1.8-2.0 
indicates high quality RNA. For long term storage, RNA was kept at -80℃.  
2.4.2 cDNA synthesis 
Using anchored-oligo(dT)18 primers and the Transcriptor First Strand 
cDNA Synthesis Kit according to manufacturer’s instruction, 200 ng total 
RNA was reverse transcribed. The reaction conditions were either as described 
in the original instruction: 30 minutes at 55°C, or in a modified reaction: 10 
minutes at 25°C, 60 minutes at 42°C, 5 minutes at 99 °C (the last 5-minute 
step to inactivate the enzyme). 
2.4.3 Validation of PCR primers 
 PCR primers were designed by using NCBI database and Primer3 online 
program, and synthesized by a commercial source (Integrated DNA 
Technologies, Singapore). Table 2.3 shows the list of primers tested. 
Standard PCR reaction was first performed to validate these PCR primers 
using GoTaq Flexi DNA polymerase kit (Promega, USA) with a total reaction 
volume of 10 μl consisting of 2 μl of 5X Green GoTaq Flexi Buffer, 0.4 μl of 
25mN magnesium chloride solution, 1 μl of dNTP mixture (2 mM ATP; 2 mM 
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GTP; 2 mM CTP; 2 mM TTP), 0.25 μl of 10 uM forward primer, 0.25 μl of 10 
uM reverse primer, 0.2 μl of Taq polymerase (5 units/μl) and 0.5 to 1 μl of 
template DNA, with addition of MilliQ water adjusted accordingly to final 
volume of 10 μl.  
A typical PCR reaction was set up with the cycling conditions as follows: 
initialization at 95 °C for 5 minutes; 25 to 30 cycles of denaturation at 95 °C for 
30 seconds, annealing at 55 to 62 °C for 1 minute, extension at 72 °C for 45-90 
seconds; final extension at 72 °C for 10 minutes. All PCR products were 
analyzed on 1% agarose gel stained with SYBR® Safe DNA Gel Stain 
(Invitrogen, USA) and visualized using an ultraviolet transilluminator in a gel 
documentation system Gel Doc XR (Bio-Rad Laboratories, USA). Table 2.3 






Table. 2.3 primer list tested in this study 
Gene 
name 
 Primer sequence 
bactin2 forward CATCACACCTTCTACAATGAGC 
 reverse CATCACACCTTCTACAATGAGC 
fabp10a forward TTCAGCGGGACGTGGCA 
 reverse CGCTTCAGATCTTCTTGC 
DsRed forward GTAATGCAGAAGAAGACTATGGGCTGGGAG 
 reverse ATGTCCAGCTTGGAGTCCACGTAGTAGTAG 
apoa1 forward GTGGCTCTTGCACTGACTCT  
 reverse AGCTGGAGTTTGTACTGCTCA  
apobl forward TCGTGACATGAGCGAAGTGG 
 reverse TGGTGTGGGAATGGTCAACT 
acox1 forward CGTGCTCTTGAAACCACTGC 
 reverse GGGCCCAATATCACCAACGA 
apob forward CCTCTCACTGGCGAGACAAG 
 reverse TCAGGAATCTGGAGGTCGGT 
rbp2a forward AATGCCAGCCGATTTCAACG 
 reverse CATCCCACTTTACCAGGGTCTTA 
rbp2b forward CCGCAAGATTGCAGTTCACC 





2.4.4 Quantitative PCR 
Quantitative PCR was carried out with LightCycler 480 SYBR Green I 
Master-Kit (Roche) following the MIQE (Minimum Information for 
Publication of Quantitative Real-Time PCR Experiments) guidelines (Bustin et 
al., 2009). 
Real-time PCR was performed using the LightCycler® Instrument and the 
LightCycler® FastStart DNA Master SYBR Green I Kit together with 1 µl 
cDNA as a template. For amplification and detection of 3´ and 5´ β-actin 
amplicons, two pairs of primers were designed against zebrfish β-actin 
sequence. PCR conditions were: 10 minutes pre-incubation step at 95°C; 50 
cycles of 10 seconds at 95°C, 15 seconds at 60°C and 30 seconds at 72°C. The 
3 /´5 r´atio was determined in relation to cDNA transcribed from an intact RNA 
(calibrator) using the LightCycler® Relative Quantification Software. 
Quantitative analyses were based on Ct values from both treated group and 
control group, including both target genes and housekeeping gene. The relative 
expression ratio (fold change) was calculated based on ΔΔCt. ΔΔCt = (Ct,target 
−Ct,β-actin)treatment −(Ct,target −Ct,actin)control, and fold change = 2
-ΔΔCt
. 
2.5 Cell proliferation assays 
  Zebrafish larvae were fixed in 4% paraformaldehyde in phosphate-buffered 
saline overnight, embedded in OCT compound for cryo-section at 5 μm 
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thickness. To identify cell proliferation, PCNA antibody (AnaSpec, Singapore) 
together with the EnVision+System-HRP (DAB) kit (DakoCytomation, 
Denmark) was used to visualize proliferating cells counter-stained with DAPI 
(4′-6-Diamidino-2-phenylindole). Liver cell counts were obtained from 6 
embryos at 120 hpf (embryos were treated with 50 μg/L E2, 1000 ng/L TCDD, 
100 μg/L NDMA from 3 hpf to 120 hpf). We compared treated groups and 
control group. 
2.6 Fluorescence-activated cell sorting (FACS) for determination of 
neutrophils number  
Tg(lysC:DsRed2) larvae at 5 dpf, which had been treated with several 
different chemicals were trypsinized (approximately 150 larvae per experiment) 
and sorted by FACS. Embryos were rinsed for 15 min in calcium free Ringer 
and passed several times through a 200 μL pipette tip. Embryos were 
transferred into a 35 mm culture dish with 2 mL phosphate buffered saline 
(PBS, pH 8) containing 0.25% trypsin and 1 mM EDTA and incubated for 30 
to 60 min at 28.5°C during which they were triturated with a 200 μL pipette 
tip every 10 min. The digest was stopped by adding CaCl2 to a final 
concentration of 1 mM and fetal calf serum to 10%. Cells were centrifuged for 
3 min at 3000 rpm, rinsed once with PBS and resuspended at 10
7
 cells/mL 
with Leibovitz medium L15 without phenol red, 1% fetal calf serum, 0.8 mM 
CaCl2, penicillin 50 U/mL and streptomycin 0.05 mg/mL. FACS of single cell 
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suspensions was performed at room temperature under sterile conditions using 
a FACSVantage SE/DIVA (Becton Dickinson) with a Coherent Innova 70 laser 




 cells were separately collected 
in L15, 0.8 mM CaCl2, 10% fetal calf serum, 10% zebrafish embryo extract, 
penicillin 50 U/mL and streptomycin 0.05 mg/mL. Following sorting, cell 
viability was greater than 90%. Neutrophil cells number from RFP transgenic 


















3.1 FT-DarT tests and comparison with DarT 
 In the present project, nine fluorescent transgenic zebrafish lines were selected 
and these transgenic zebrafish have targeted GFP/RFP expression in a wide 
range of tissue/organs, including the liver, pancreas, blood vessels, skin, muscle, 
central nervous system, blood cells, mantle cells of lateral line etc. (Table 2.1) 
For each fluorescent transgenic zebrafish line, specific GFP/RFP expression in 
all chemical-treated embryos between 3 to 120 hpf was examined. In addition, 
all the endpoints based on the DarT protocol in Table 1.1 (Nagel, 2002a), 
mainly including survival, tail detachment, somite formation, edema, hatching 
and heart beat were also examined. The nine fluorescent transgenic lines were 
tested with 24 different chemicals of several categories (Table 2.2). 
3.1.1 Tg(nkx2.2a:mEGFP)  
 Tg(nkx2.2a: mEGFP) have EGFP expression mainly in the nervous system, 
including brain and ventral neural tube, as well as in developing pancreas and a 
subset of cells scattered throughout the intestinal epithelium (Ng et al., 2005). 
For this transgenic line, we tested the following chemicals with several different 
concentrations: acetaminophen ( 0.5, 1, 2, 2.5, 5, 10, 20, 25 mg/L), atenolol 
( 0.25, 0.5, 0.8, 1, 2.5, 5, 7.5, 10 mg/L), atrazine (0.25, 0.5, 0.8, 1, 2, 3, 4, 5 
mg/L), ethanol ( 0.025%, 0.05%, 0.08%, 0.1%, 0.25%, 0.5%, 1%, 2%), 
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17β-estradiol (5, 10, 50, 100, 1000 μg/L), lindane ( 0.25, 0.5, 1, 1.25, 2.5, 5, 10, 
20 mg/L), mefenamic acid (5, 10, 50, 100, 250 μg/L). 
 As shown in Fig. 3.1, comparing those in 0.01%DMSO vehicle control, the 
larvae in 5 mg/L acetaminophen, 2.5 mg/L atenolol, 2 mg/L atrazine, 0.5% 
ethanol, 1.25 mg/L lindane appeared to be normal under the bright-field view, 
but showed short axons under the dark-field view for GFP fluorescence. In 
comparison, in 250 μg/L mefenamic acid (a NSAID-pain killer), even though 
the fish already had edema as observed under a bright-field view, the axon 
length was not affected, indicating the specificity of the assay for neurotixicity. 
 Table 3.1 shows the sensitivity we tested based on both DarT endpoints and our 
transgenic fluorescent DarT (FT-DarT) endpoint. For example, only from 5 
mg/L or above, atenolol affected the DarT endpoints (i.e. survival rate, hatching 
rate, edema rate with statistical significance); however, from the FT-DarT 
endpoint (axon length), 0.5 mg/L atenolol was sufficient to cause statistically 
significant reduction of axon length.  
 We later found that the shortening of axons was very sensitive to several other 
neurotoxins and we further characterized this transgenic line and developed a 






Fig. 3.1 Chemical tests in Tg(nkx2.2a:mEGFP). General phenotypes (left 
column), GFP-expressing central nervous systems (middle column) and 
motoneuron axons (right column) of 80-hpf Tg(nkx2.2a:mEGFP) fry in the 
presence of effective concentrations of different chemicals: (A) 0.01% DMSO 
control, (B) 5 mg/L Acetaminophen, (C) 2.5 mg/L Atenolol, (D) 2 mg/L 
Atrazine, (E) 0.5% Ethanol, (F) 1.25 mg/L Lindane and (G) 250 μg/L 
Mefenamic acid. Scale bars: 1000 μm for the left and middle columns and 100 
μm for the right column. 
 




DarT  FT-DarT (nkx2.2a)  
Acetaminophen  10 mg/L  1 mg/L  
Atenolol  5 mg/L  0.5 mg/L  
Atrazine  3 mg/L  0.5 mg/L  
Ethanol  0.25%  0.05%  
Lindane  1.25 mg/L  0.5 mg/L  




The Tg(fli1:EGFP) line has targeted GFP expression in blood vessels 
(including major trunk vessels, intersegmental vessels) (Lawson and Weinstein, 
2002). With this transgenic line, we tested the following chemicals with the 
following concentration in parentheses: 17β-estradiol (5, 10, 50, 100, 1000 
μg/L), lindane (1.25, 2.5, 5, 10, 20 mg/L), arsenate (10, 50, 100, 250, 500 μg/L), 
and TCDD ( 10, 125, 250, 500, 1000 μg/L). 
As shown in Fig. 3.2, after 17β-estradiol treatment, the fry seemed to be 
normal under bright-field view. When the dose was lower than 10μg/L, under 
both the bright-field view and GFP dark view, the fry seemed normal. However, 
in the high dose groups from 50 μg/L above, GFP intensity in intersegmental 
blood vessels was decreased. Especially at 100 μg/L and 1000 μg/L, there was 
dramatic reduction of GFP intensity as if the intersegmental vessel was broke 
off; actually, they remained intact by careful examination of the images. After 
lindane treatment, the fry appeared to be normal when the dose was lower than 5 
mg/L, but became scoliosis when the dose was higher than 10 mg/L, and GFP 
intensity of intersegmental blood vessels was also decreased from 10 mg/L and 
above dose. In contrast, in arsenate treatment, even with around 15% fry 
became scoliosis in a high dose of 500 μg/L, the GFP intensity of blood vessels 
still seemed to be normal in these fry. In TCDD treatment group, in all doses 
(1000, 500, 250, 125 and 100 ng/L), the treated fry seemed to be normal from 
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both bright-field view and GFP dark view; thus, TCDD may not significantly 
affect the blood vessels. 
Table 3.2 compare chemical sensitivities of Tg(fli1:EGFP) based on both 
DarT and FT-DarT endpoints. It seems that only for 17β-estradiol, the FT-DarT 
endpoint (GFP intensity of intersegmental blood vessels) was more sensitive 
than DarT endpoint, as it could detect as low as 10 μg/L 17β-estradiol, while the 
DarT endpoints could only detect 50 μg/L 17β-estradiol. However, for lindane, 






Fig. 3.2 Chemical tests with Tg(ﬂi1:EGFP). General phenotypes (left 
column), GFP-expressing blood vessel (middle column) and intersegmental 
blood vessel (right column) of 80-hpf Tg(fli1: EGFP) fry in the presence of 
effective concentrations of different chemicals: (A) 0.01% DMSO control, (B) 
10 μg/L 17β-estradiol, (C) 100μg/L 17β-estradiol, (D) 10 mg/L Lindane, (E) 
500 μg/L Arsenate, (F) 1000 ng/L TCDD. 
 
Table 3.2 Testing sensitivity from DarT & FT-DarT endpoint for Tg(fli1: 
EGFP) 
Chemical  DarT  FT-DarT (fli)  
17β-estradiol  50 μg/L  10 μg/L  
Lindane  1.25 mg/L  10 mg/L  
Arsenate  50 μg/L  500 μg/L  




3.1.3 Tg( krt8: EGFP) 
 The expression pattern of Tg(krt8:EGFP) line is at the surface layer of 
stratiﬁed epithelial tissues, including skin epidermis, epithelia of mouth, 
pharynx, esophagus, and rectum (Gong et al., 2002). For this transgenic line, we 
tested two chemicals with several different concentration: lindane (1.25, 2.5, 5, 
10, 20 mg/L), arsenate (10, 50, 100, 250, 500 μg/L). 
As shown in Fig. 3.3, after lindane treatment, when the dose was below 2.5 
mg/L, the fry seemed to be normal under both bright-field view and GFP dark 
view; however, at high doses from 5 mg/L, the fry showed scoliosis in 
phenotype. Under the GFP view, GFP intensity in skin epithelia did not change 
much. In arsenate treatment under low doses of 10 μg/L and 50 μg/L, the fry 
appeared to be normal, but at the concentrations of 100 μg/L and 500 μg/L, even 
though the fry appeared to be normal under the bright-field view, the GFP 
intensity of skin increased obviously under the GFP view. 
Table 3.3 summarizes the sensitivity of DarT and FT-DarT endpoints of 
Tg(krt8:EGFP). The FT-DarT endpoint (change of skin GFP intensity) did not 
improve the test sensitivity for both lindane and arsenate compared to available 







Fig. 3.3 Chemical tests in Tg(krt8: EGFP). General phenotypes (left column), 
GFP-expressing skin (middle column) and skin (right column) of 120-hpf 
Tg(krt8: EGFP) fry in the presence of effective concentrations of different 
chemicals: (A) 0.01% DMSO control, (B) 5 mg/L Lindane, (C) 100 μg/L 
Arsenate. 
 
Table 3.3 Testing sensitivity from DarT & FT-DarT endpoint for Tg(krt8: 
EGFP) 
Chemical  DarT  FT-DarT (krt8)  
Lindane  1.25 mg/L  5 mg/L  








3.1.4 Tg(krt8:EGFP; mylz2: DsRed) 
Tg(krt8:EGFP; mylz2:DsRed) is a double transgenic line, with GFP 
expression in the skin and RFP expression in fast skeletal muscles (Wan et al., 
2002). For this transgenic line, we tested the following chemicals with several 
different concentration: lindane (1.25, 2.5, 5, 10, 20 mg/L), arsenate (10, 50, 
100, 500, 1000 μg/L) and mefenamic acid (5, 10, 50, 100, 250 μg/L). 
Fig. 3.4 shows that after exposure to 5 mg/L or lower dose of lindane, the fry 
seemed to be normal; however, when the dose was higher than 10 mg/L, even if 
the fry appeared to be abnormal under the bright-field view, the skin GFP and 
muscle RFP remained unchanged. After arsenate treatment, when the dose was 
below 50 μg/L, the fry seemed to be normal, but when the dose was higher than 
100 μg/L, the skin GFP intensity increased a lot, which was consistent with the 
results in 3.1.3. While the muscle RFP intensity and muscle fiber did not change 
much when compared with the control group. We also observed that in 
mefenamic acid treatment, when the concentration was 5 μg/L, the fry appeared 
to be normal under both bright-field view and fluorescent dark view; but when 
the concentration was above 10 μg/L, the muscle RFP intensity decreased 
obviously while the skin GFP expression pattern did not have much change. 
From Table 3.4, we could infer that for all these three chemicals (lindane, 
arsenic, mefenamic acid), the FT-DarT endpoints (both skin GFP and muscle 




Fig. 3.4 Chemical tests in Tg( krt8: EGFP; mylz2: DsRed). General 
phenotypes (left column), GFP-expressing skin (middle column) and 
RFP-expressing muscle (right column) of Tg( krt8: EGFP; mylz2: DsRed) fry 
in the presence of effective concentrations of different chemicals: (A) 0.01% 
DMSO control, (B) 10 mg/L Lindane, (C) 1000 μg/L Arsenate, (D) 0.01% 
DMSO control, (E) 10 μg/L Mefenamic acid.  
 
Table 3.4 Testing sensitivity from DarT & FT-DarT endpoint for Tg(krt8: 
EGFP;mylz2:DsRed) 
Chemical  DarT  FT-DarT (krt8/mylz2)  
Lindane  1.25 mg/L  10 mg/L  
Arsenate  100 μg/L  500 μg/L  





3.1.5 Tg(lfabf:DsRed; elaA:EGFP) (LiPan) 
 Tg(lfabf:DsRed; elaA:EGFP) (LiPan) has liver-specific RFP expression and 
exocrine pancreas-specific GFP expression (Korzh et al., 2008b). We first tested 
4 chemicals with different concentrations in this transgenic line, mefenamic 
acid (5, 10, 50, 100, 250 μg/L), amoxicillin (0.1, 0.5, 1, 2, 5 mg/L), 
17β-estradiol (1, 5, 10, 50, 100 μg/L), and N-nitrosodimethylamine (NDMA) 
(0.1, 1, 10, 25, 100 μg/L). 
 As shown in Fig. 3.5, comparing with 0.01% DMSO control, the fry in 10 
μg/L17β-estradiol appeared to be normal under a bright-field view, but lost tail 
pancreas marked by GFP expression. At 50 μg/L of mefenamic acid, the liver 
size was greatly reduced. In contrast, 10 μg/L N-nitrosodimethylamine (NDMA) 
resulted in enlarged livers. However, in 2 mg/L amoxicilin, the liver and 
pancreas appeared to be normal. For all these conditions, the changes of liver 
and pancreas were not observable by the standard DarT protocol as shown in the 
pictures in bright-field views (left). 
 In Table 3.5, we concluded that FT-DarT could improve the test sensitivity of 
17β-estradiol and NDMA, based on liver enlargement phenotype. We later 
found that the change of liver RFP intensity and liver size were very sensitive 
endpoints for testing of hepatotoxins; thus, we developed a sensitive 





Fig. 3.5 Chemical tests in Tg (lfabf:DsRed; elaA:EGFP). General 
phenotypes (left column), GFP-expressing pancreas (middle column) and 
RFP-expressing liver (right column) of Tg (lfabf:DsRed; elaA:EGFP) fry in the 
presence of effective concentrations of different chemicals: (A) 0.01% DMSO 
control, (B) 10 μg/L 17β-estradiol, (C) 50 μg/L Mefenamic acid, (D) 10 μg/L 
NDMA, (E) 2 mg/L Amoxicillin. 
 
Table 3.5 Testing sensitivity from DarT & FT-DarT endpoint for Tg 
(lfabf:DsRed; elaA:EGFP) 
Chemical  DarT  FT-DarT (lfabp/elaA)  
17β-estradiol  50 μg/L  1 μg/L  
Mefenamic acid  10 μg/L  10 μg/L  
NDMA  10 μg/L  1 μg/L  





Tg(ins:gfp) expresses GFP in insulin-producing cells in endocrine islets of 
pancreas (Huang et al., 2001). Only lindane (0.25, 0.5, 1, 1.25, 2.5, 5, 10, 20 
mg/L) was tested with this transgenic line. 
 In Fig. 3.6, compared with 0.01% DMSO control, when the lindane dose 
was below 10 mg/L, the fry appeared to be normal under the bright-field view. 
For GFP dark view, when the dose was below 1 mg/L, the islet also seemed to 
be normal; however, from 1.25 mg/L and above, smaller islets of pancreas were 
observed based on GFP fluorescence (Fig. 3.6 B). At a dose of 20 mg/L, the fry 
became scoliosis, and the swim pattern was affected; moreover, the islets 
became even smaller than those at lower doses (Fig. 3.6 C). 
Table 3.6 shows that from FT-DarT endpoint (size of islet), sensitivity was 







Fig. 3.6 Chemical tests in Tg (ins:gfp). General phenotypes (left column), 
GFP-expressing islet (middle column) and islet (right column) of Tg (ins:gfp) 
fry in the presence of effective concentrations of different chemicals: (A) 0.01% 
DMSO control, (B) 1.25 mg/L Lindane, (C) 20 mg/L Lindane. 
 
Table 3.6 Testing sensitivity from DarT & FT-DarT endpoint for Tg (ins:gfp) 
Chemical  DarT  FT-DarT (ins)  






 Tg(gata1:dsRED) has RFP expression in circulating blood cells (Traver et al., 
2003). We tested the following chemicals with several different concentrations 
in this transgenic line: atenolol ( 0.25, 0.5, 0.8, 1, 2.5, 5, 7.5, 10 mg/L), 
17β-estradiol (5, 10, 50, 100, 1000 μg/L), and lindane ( 0.25, 0.5, 1, 1.25, 2.5, 5, 
10, 20 mg/L). 
As shown in Fig. 3.7, comparing with 0.01% DMSO vehicle control, the 
fry in all tested doses of atenolol and 17β-estradiol appeared to be normal under 
both a bright-field view and a RFP view; meanwhile, at 5 mg/L of lindane or 
lower, the fry also appeared to be normal under both bright-field view and RFP 
view. Only when the lindane dose was above 10 mg/L, the treated fry appeared 
to have abnormal morphology such as scoliosis, but RFP fluorescence appeared 
to be unchanged. Thus, no apparent altered fluorescent marker was observed 
from this transgenic line. 
In Table 3.7, it is apparent that FT-DarT endpoint did not improve test 
sensitivity than classical DarT endpoints. After atenolol, 17β-estradiol, and 
lindane treatment, the phenotype of fry and the RFP view did not change a lot. 
This may be due to the rapid flow of the blood cells, and we could not capture 
images of individual blood cells by a relatively long exposure time under the 





Fig. 3.7 Chemical tests in Tg(gata1:dsRED). General phenotypes (left 
column), RFP-expressing blood cells (flow) (middle column) and blood cells 
(flow) (right column) of Tg(gata1:dsRED) fry in the presence of effective 
concentrations of different chemicals: (A) 0.01% DMSO control, (B) 5 mg/L 
Atenolol, (C) 0.01% DMSO, (D) 50 μg/L 17β-estradiol, (E) 1.25 mg/L Lindane. 
 
Table 3.7 Testing sensitivity from DarT & FT-DarT endpoint for 
Tg(gata1:dsRED) 
Chemical  DarT  FT-DarT (gata1)  
Atenolol  5 mg/L   10 mg/L  
17β-estradiol  10 μg/L  1,000 μg/L  






3.1.8 ET10 (Enhancer trap line 10) 
ET10 is an enhancer trap transgenic line with EGFP expression in the mantle 
cells of neuromasts of the lateral line, branchial arches, tendons, a subset of 
interneurons in the dorsal spinal cord, pronephros and olfactory pits (Choo et al., 
2006). Only lindane (0.25, 0.5, 1, 1.25, 2.5, 5, 10, 20 mg/L) was tested with this 
transgenic line.  
Fig. 3.8 shows that, compared with 0.01% DMSO control, the ET10 fry in 1 
mg/L or lower dose of lindane, the fry appeared to be normal under both 
bright-field and GFP views; however, when the dose was above 1.25 mg/L, the 
treated fry appeared to be normal under a bright-field view, but the mantle cells 
of the lateral line and olfactory pits seemed to be irregular under GFP view. 
When the dose was higher than 5 mg/L, the fry became abnormal even under 
bright-field view, as well as the GFP dark view. 
As shown in Table 3.8, for lindane, FT-DarT end point of this line (shape of 







Fig. 3.8 Chemical tests in ET10. General phenotypes (first column), 
GFP-expressing skin (second column), the mantle cells of neuromasts and the 
lateral line (third column), olfactory pits (fourth column) and mantle cell (fifth 
column) of ET10 fry in the presence of effective concentrations of different 
chemicals: (A) 0.01% DMSO control, (B) 1.25 mg/L Lindane. 
 
 
Table 3.8 Testing sensitivity from DarT & FT-DarT endpoint for ET10 
Chemical  DarT  FT-DarT (ET10)  







  The treatment methods for Tg(lysC:DsRed2) was different from those for 
other fluorescent transgenic lines and we performed chemical treatments from 7 
dpf to 8 dpf, instead of from 3 hpf to 5 dpf. 
  As shown in Fig. 3.9, for the Tg(lysC:DsRed2) fry, after treatment with heavy 
metals (6 mg/L Pb, 200 μg/L Cd or 100 μg/L Zn), the RFP labeled neutrophils 
were markedly increased, indicating inflammation reaction in the fry body.  
  As Tg(lysC:DsRed2) has been established for inflammation assay and 
obvious increase of neutrophils was observed by using the three different heavy 
metals, we envisage that this transgenic line may be valuable for testing 
inflammatory chemicals in environmental toxicology. Thus, we performed 
further experiments to test a variety of environmental toxicants by using this 








Fig. 3.9 Chemical tests in Tg(lysC:DsRed2). The left column shows general 
phenotype and the right column shows RFP-expressing neutrophils. (A) egg 





3.1.10 Summary of tested lines and chemicals 
Table 3.9 summarized the sensitivity for each chemical by DarT points in 
wild-type embryos. For each chemical, with wild-type embryos, the most 
sensitive concentration by DarT endpoints is as follows: 5mg/L acetaminophen, 
0.5 mg/L chlorphenamine, 1 mg/L amoxicillin, 10 μg/L mefenamic acid, 5 
mg/L atenolol, 5 mg/L aspirin, 5 mg/L isoniazid, 0.5 mg/L phenylbutazone, 50 
μg/L 17β-estradiol, 5 mg/L bisphenol-A, 3 mg/L atrazine, 1.25 mg/L lindane, 






Table 3.9 Test sensitivity of DarT endpoints for wild-type zebrafish embryos 
 
Time 
 8 hpf 24 hpf 48 hpf 96 hpf – 120 hpf 






















rate Hatching  
Without 
edema  
Acetaminophen (mg/L) 10 10 10 10 10 10 10 10 5 10 10 10 
Chlorphenamine (mg/L) 1 1 1 1 1 1 1 1 1 0.5 0.5 0.5 
Amoxicillin (mg/L) 2 2 2 2 2 2 2 2 1 1 1 1 
Mefenamic acid (μg/L) 10 10 10 10 10 10 10 10 100 10 10 10 
Atenolol (mg/L) 10 10 10 10 10 10 10 10 10 5 5 5 
Aspirin (mg/L) 10 10 10 10 10 10 10 10 10 5 5 5 
Isoniazid (mg/L) 10 10 10 10 10 10 10 10 5 5 5 5 
Phenylbutazone (mg/L) 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.5 0.5 0.5 0.5 
17β-estradiol (μg/L) 100 100 100 100 100 100 100 100 50 100 50 50 
Bisphenol-A (mg/L) 8 8 8 8 8 8 8 8 5 5 5 5 
Atrazine (mg/L) 5 4 4 4 4 4 4 4 5 4 4 3 
Lindane (mg/L) 10 5 5 5 5 5 5 5 1.25 5 2.5 2.5 
NDMA (μg/L) 100 100 100 100 100 50 50 50 50 25 10 10 
Arsenate (μg/L) 250 250 250 250 250 100 100 100 250 100 100 100 
Ethanol (%) 2 2 2 2 2 1 1 1 0.5 0.5 0.5 0.5 
TCDD (ng/l) 500 500 500 500 500 250 250 250 250 250 250 250 
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Table 3.10 summarizes all chemical tests so far we have conducted using the 
9 transgenic lines in comparison with the data obtained in parallel with the DarT 
tests. Grey boxes were those we have not yet tested. Pink boxes indicate that no 
significant improvement was obtained by FT-DarT when compared with the 
most sensitive DarT endpoint. Red boxes represent those FT-DarT assays very 
significantly improved in the test sensitivity compared to DarT endpoint, as 
supported by statistical analyze. 
To sum up, among all the fluorescent transgenic lines tested, we identified 
three transgenic lines that are particularly useful for development of specific 
assays including neurotoxicity assay using Tg(nkx2.2a:mEGFP), 








Table 3.10 Fish lines & chemicals tests     
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NDEA          # 
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Copper  #          # 
Zinc #          # 
Lead #          # 
Mercury  #          # 
Cadmium #          # 
Chronium #          # 
Others  Ethanol  #  #     #     
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3.2 Tg(nkx2.2a:mEGFP) for neurotoxin screen 
3.2.1 Evaluation of developmental toxicity with selected DarT endpoints 
Six chemicals with a range of five different concentrations were tested, 
including acetaminophen (2.5, 5, 10, 20, 25 mg/L), atenolol (1, 2.5, 5, 7.5, 10 
mg/L), atrazine (1, 2, 3, 4, 5 mg/L), ethanol (0.1%, 0.25%, 0.5%, 1%, 2%,), 
lindane (1.25, 2.5, 5, 10, 20 mg/L), and mefenamic acid (5, 10, 50, 100, 250 
μg/L) (Table 3.11). 
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DMSO 0.01% 94.5 86.5 85.5 86.0 85.5 84.5 84.5 84.5 36 84.0 84.0 83.0 + + 3331 3163 43.5 
Acetaminophen 
(mg/L) 
2.5 97.0 84.5 84.5 84.5 84.5 83.5 83.5 83.5 35 83.5 83.5 82.5 + + 3364 3053 26.1 
5 93.5 86.0 85.0 85.5 84.5 86.0 85.5 86.0 33 85.5 84.5 85.0 + + 3352 3078 20.9 
10 89.0 71.5 69.5 70.0 69.5 69.5 69.5 69.5 31 69.5 62.0 68.0 +/- +/- 3350 2988 16.2 
20 80.5 68.0 65.5 66.5 64.5 67.0 66.0 67.0 29 65.5 54.5 59.0 +/- +/- 3244 2922 14.7 
25 73.5 61.0 57.0 58.5 56.0 59.5 58.5 59.0 24 58.0 45.5 49.0 +/- +/- 3197 2911 7.7 
DMSO 0.01 94.0 85.5 84.5 85.0 84.5 84.5 84.5 84.5 35 84.0 83.5 83.5 + + 3339 3093 48.0 
Atenolol (mg/L) 1 92.0 84.5 83.0 83.5 83.0 83.5 83.5 83.5 34 82.0 81.0 81.0 + + 3105 2914 26.8 
2.5 92.5 86.5 84.0 84.5 83.5 85.0 85.0 85.0 35 80.5 78.0 78.5 + + 3225 3000 22.1 
 
5 93.0 81.5 78.5 79.0 77.5 78.5 78.5 78.5 34 74.5 70.5 71.5 + + 3251 2999 21.0 
 
7.5 89.0 78.5 75.0 76.5 73.5 75.5 75.5 75.5 33 70.0 65.0 59.0 +/- + 3316 3061 11.2 
 
10 84.5 66.5 60.0 63.0 58.5 63.0 61.5 63.0 32 61.5 55.5 49.0 +/- +/- 3176 2869 11.2 
DMSO 0.01 94.0 88.0 87.5 87.5 87.5 87.5 87.5 87.5 36 87.0 86.5 87.0 + + 3341 2926 48.7 
Atrazine (mg/L) 1 94.5 87.0 86.5 86.5 86.5 86.0 86.0 86.0 35 85.5 84.0 84.5 + + 3305 2891 24.6 
2 94.5 84.5 83.0 83.5 83.5 83.5 83.5 83.5 37 83.5 82.0 81.5 +/- + 3204 2715 19.6 
 
3 89.5 81.0 78.5 79.5 78.5 78.5 78.0 78.5 36 77.5 72.0 74.5 +/- +/- 3122 2883 15.4 
 
4 85.0 77.0 74.0 75.0 72.5 71.0 71.0 71.0 38 70.5 65.0 66.5 - +/- 3177 2753 13.6 
 
5 84.5 73.5 67.5 69.0 66.0 66.5 66.5 66.5 40 65.0 56.0 59.5 - +/- 3109 2805 12.1 
Egg water 
 
94.5 86.5 85.5 86.0 85.5 84.5 84.5 84.5 36 84.0 84.0 83.0 + + 3388 3106 46.3 
Ethanol  
(by volume) 
0.10 93.0 84.5 84.5 84.5 84.5 84.0 84.0 84.0 35 84.0 84.0 83.0 + + 3231 3028 28.8 
0.25 92.5 86.0 85.0 85.5 84.0 82.0 82.0 82.0 33 80.5 80.0 78.5 + + 3191 2971 15.8 
0.50 90.5 84.5 81.0 81.5 76.5 79.5 79.5 79.5 29 77.0 72.5 72.0 +/- + 3154 2923 14.6 
 
1 85.5 76.5 69.5 72.5 67.5 71.0 70.0 70.5 27 69.5 53.0 60.0 +/- +/- 3185 2986 12.0 
 
2 74.5 68.5 54.5 59.0 49.5 56.0 54.5 55.0 22 52.5 34.0 41.5 - +/- 3083 2847 5.7 
DMSO 0.01 94.0 87.5 87.5 87.5 87.5 87.0 87.0 87.0 36 87.0 87.0 87.0 + + 3342 3171 46.0 
Lindane (mg/L) 1.25 93.5 86.5 86.0 86.5 85.5 85.5 85.5 85.5 34 84.5 84.0 83.5 + + 3164 2998 28.9 
2.5 92.5 83.5 82.5 83.0 82.5 82.0 82.0 82.0 32 82.0 81.5 80.5 +/- +/- 2993 2846 22.6 
 
5 90.0 71.5 69.0 69.5 67.5 68.5 68.5 68.5 30 67.0 64.0 62.5 - +/- 2952 2802 12.8 
 
10 89.5 64.0 61.0 62.5 60.0 62.5 61.5 62.5 28 61.5 54.5 56.5 - +/- 2915 2712 9.4 
 
20 87.5 55.5 52.0 53.0 49.0 52.5 52.0 52.5 25 51.5 44.5 46.0 - +/- 2959 2797 6.7 
DMSO 0.01 94.0 87.5 87.0 87.5 87.0 87.0 87.0 87.0 36 87.0 86.5 86.5 + + 3319 3011 47.1 
Mefenamic Acid 
(μg/L) 
5 90.0 84.0 83.5 84.0 83.0 81.0 81.0 81.0 36 80.5 80.5 79.5 + + 3235 2926 47.2 
10 88.0 78.5 76.5 78.0 76.0 77.0 76.5 77.0 37 76.0 74.0 75.0 + + 3247 2999 48.6 
50 84.5 70.5 69.5 70.0 67.0 69.5 69.5 69.5 38 69.5 64.5 66.5 +/- +/- 3202 2965 47.3 
 
100 82.0 67.5 64.5 65.0 61.5 64.0 64.0 64.0 33 56.5 44.5 46.5 +/- +/- 2963 2842 42.8 
  250 78.5 56.0 51.5 52.0 39.5 48.5 48.5 48.5 23 42.0 38.5 35.5 - - 2928 2797 37.9 
Groups with highly significant difference (P<0.01) from controls are indicated in red and with significant difference (P<0.05) in yellow based on 
t-test.  
Touch response: + (normal), +/- (slow response, jump), - (no response, not moving) 
Pigment: + (normal), +/- (light pigmentation), - (no or little pigmentation) 
Table 3.11. Comparison of sensitivity of lethal and sublethal DarT endpoints and axon length measurements in Tg(nkx2.2a:mEGFP)  
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0.01% DMSO was used as vehicle control for all of them except for ethanol, 
which is water soluble and egg water was used as the control. First, we noticed a 
dosage-dependent decrease of survival rates for all of the six tested chemicals at 
all of the four time points (8, 24, 48 and 96 hpf) (Fig. 3.10). Generally, for all six 
chemicals, the survival curves for the last three time points were quite similar 
while the survival rates are much higher at 8 hpf, indicating that most of 
mortalities occurred between 8-24 hpf. For the highest dosage groups, 42.0-65.0% 






Fig. 3.10 Survival rates of Tg(nkx2.2a:mEGFP) fry in the presence of 
different concentrations of testing chemicals. Survival rates at 8, 24, 48 and 
96 hpf against different concentrations of the chemicals. Chemical names are 





There was also a dosage-dependent decrease hatching rates for all six 
chemicals (Fig. 3.11A), with suppression of the hatching rates to 34%-56% in 
their highest concentration groups. These observations further indicate the 







Fig. 3.11 Summary of selected DarT endpoint measurements. (A) Hatching 
(96 hpf), (B) Heartbeat (48 hpf), (C, D) Tail detachment (24 hpf, 48 hpf), (E, F) 
Normal somite (24 hpf, 48 hpf). Names and concentrations of chemicals are 
indicated at the bottom of Panel F. 0.01% DMSO was used as control except 
that egg water was used as control for ethanol test. Hearbeat is shown as 
numbers per 15-second. Statistical significance: **P<0.01; *P<0.05. 
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We also examined several other DarT endpoints, including tail detachment 
and somite formation at 24 hpf and 48 hpf; spontaneous movement at 24 hpf; 
heart beat at 48 hpf; hatching at 96 hpf; edema, touch response and 
pigmentation between 90-120 hpf (Table 3.11). Some examples of the 
abnormalities are shown in Fig. 3.12, such as no tail detachment (Fig. 3.12B), 
no somite formation (Fig. 3.12C), edema (Fig. 3.12E), light pigmentation (Fig. 
3.12F), lack of hatching (Fig. 3.12G), in comparison with matched controls (Fig. 
3.12A and 3.12D). Statistics of some of these abnormalities are presented in Fig. 





Fig. 3.12 Examples of abnormal phenotypes. (A, D) Normal developing 
control embyors/fry in o.01% DMSO at 24 hpf (A) and 72 hpf (D); (B) No tail 
detachment at 24 hpf in 20 mg/L acetaminophen; (C) No somite at 24 hpf in 25 
mg/L acetaminophen; (E) Edema at 72 hpf in 20 mg/L lindane; (F) Light 
pigmentation at 72 hpf in 250 μg/L mefenamic acid; (G) No hatching at 72 hpf 





In general, there was a dosage-dependent effect for essentially all of the six 
chemicals on all these traits except for the heartbeat rates where acetaminophen, 
ethanol, lindane, and mefenamic acid caused dosage-dependent decrease but 
atenolol and atrazine treatments showed no significant change or slight increase 
of heartbeat (Fig. 3.11B). To evaluate the significance of difference we 
observed, T-test was used; significant difference (P=0.01-0.05) and highly 
significant difference (P<0.01) from the control groups are indicated in Fig. 
3.11 and Table 3.11. Highly significant differences for all or most of these 
endpoint measurements were observed only from high dosage groups of five of 
these chemicals and their starting concentrations were: 10 mg/L acetaminophen, 
4 mg/L atrazine, 0.5% ethanol, 5 mg/L Lindane and 10 μg/L mefenamic acid. 
For atenolol, most endpoints did not show significant difference but hatching 
and edema appeared to be quite sensitive indicators with the highly significant 
difference (p<0.01) at the concentrations of 5 and 7.5 mg/L respectively while 
most other traits did not show highly significant difference even at the highest 
dosage (10 mg/L) used (Table 3.11).  
In addition, we also observed some specific effects for these tested chemicals. 
Atrazine had a dosage-dependent increase of heartbeat rate (but with a smaller 
magnitude of heart contraction) while all other five chemicals caused a 
dosage-dependent decrease of heartbeat (Fig. 3.11B and Table 3.11). High dose 
ethanol led to obvious edema with shorter body length in a high percentage of 
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treated fry. High dose lindane generally resulted in coiled body and shorter body 
length; when these treated were touched, they had spiral-locally swimming 
pattern. For mefenamic acid, high dose groups of fry had light or no 
pigmentation (Fig. 3.12F), in addition to high percentage of edema. 
3.2.2 Axon length provides a more sensitive and measurable marker for 
evaluation of neurotoxixity  
In order to demonstrate that GFP fluorescence may provide more sensitive 
markers for phenotypical changes induced by these chemicals, GFP 
fluorescence was observed and photographed for each treatment group. As 
reported previously (Ng et al., 2005; Pauls et al., 2007) , GFP fluorescence was 
observed in the developing neural tube and brain from 1 dpf. By 3 dpf, obvious 
GFP-labeled axons were observed from motoneurons in the trunk region. As 
shown in Fig. 3.13, the larvae in the control group (0.01% DMSO or egg water) 
had well column ventral axons. In comparison, the ventral axons were either 
shortened or abolished by treatment with all of the five neurotoxins: 
acetaminophen, atenolol, atrazine, ethanol and lindane (Fig. 3.13B-F). In 
contrast, the axons were largely unaffected by the neural protectant, mefenamic 







Figs 3.13 A. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 




Figs 3.13 B. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 





Figs 3.13 C. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 
concentrations of atenolol 
 
 
Figs 3.13 D. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 





Figs 3.13 E. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 
concentrations of ethanol 
 
 
Figs 3.13 F. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 





Figs 3.13 G. General phenotypes (left column), GFP-expressing central 
nervous systems (middle column) and motoneuron axons (right column) of 
80-hpf Tg(nkx2.2a:mEGFP) fry in the presence of several different 






To further evaluate the toxic effects of these chemicals, lengths of 
anteiro-posterior body, the central nervous system (CNS) and ventral axons 
were measured. In Tg(nkx2.2a: mEGFP) line, for length measurements of 
whole body, central nervous system (CNS) and axon, ImageJ software was used. 
After setting scale for each view under each magnification in ImageJ, body 
length was measured as horizontal distance from the beginning of fish head to 
the end of tail; CNS length was measured as horizontal distance of GFP from 
brain to tail; axon length was measured as vertical distance from the beginning 
to the terminal of axon labeled by GFP for all ventral motoneuron axons from 
somite 5 to somite 14 for each fry. For each treated group, at least 5 fry were 
measured for statistical calculation. 
As shown in Fig. 3.14 and Table 3.11, only high doses of atrazine, ethanol, 
lindance and mefenamic acid showed measureable difference (P=0.01-0.05) 
compared to the control groups, but only highest concentration groups of 
ethanol (2%) and of mefenamic acid (100, 250 μg/L) showed statistically highly 
significant difference (P<0.01). For CNS length, only the two highest doses (20 
and 25 mg/L) of acetaminophen showed highly significant difference (P<0.01) 
although other four neurotoxins, but not mefenamic acid, also resulted in 





Fig. 3.14. Body length, CNS length and axon length of Tg(nkx2.2a:mEGFP) 
fry in the presence of variable chemicals. (A-C) Examples of measurements 
of body length (A), CNS length (B) and axon length (C). The measured lengths 
are indicated by double vertical lines. Scale bars: 1000 µm for up and middle; 
100 µm for the down. (D) Histograms of body length, CNS length and axon 
length. Chemical names and concentrations are indicated on the left. Statistical 
significance: **P<0.01; *P<0.05. 
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In contrast, by measurement of axon length, we found that even the lowest 
dose of all of five neurotoxins (2.5 mg/L acetaminophen, 1 mg/L atenolol, 1 
mg/L atrazine, 0.1% ethanol, 1.25 mg/L lindane) caused highly significant 
(P<0.01) shortening (Fig. 3.14 and Table 3.11). Compared to the starting 
concentrations of highly significant changes observed based on standard DarT 
endpoints examined under a bright-field microscope, the axon length endpoint 
would increase detection sensitivity by at least 2-5 fold for the five neurotoxins. 
It is interesting to note that there is no observed axon shortening from 
mefenamic acid treatment except for the highest concentration groups (100 and 
250 μg/L) while other general toxicological changes (e.g. survival rates, 
hatching, tail detachment, somite formation, edema etc) were observed at much 
lower concentration (10 μg/L), suggesting that the shortened axons by 
mefenamic acid may be a secondary effect resulted from other primary 
toxicities. These observations suggest that the axon length is a quite sensitive 
and specific endpoint for testing neurotoxicity. The axon length was generally 
correlated with the lack of or abnormal touch response (Table 3.11), which was 
dosage-dependent but an apparently less sensitive trait than axonal length.  
To further determine the maximum sensitivity of using the axon length as a 
biomarker for these neurotoxins, another test with lower ranges of neurotoxin 
concentrations was conducted. As shown in Fig. 3.15, highly significant 
difference of measured axon length (p<0.01) could be detected at the following 
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lowest concentrations: 1 mg/L acetaminophen, 0.5 mg/L atenolol, 0.5 mg/L 
atrazine, 0.08% ethanol and 0.5 mg/L lindane. Thus, compared to the starting 
concentrations of the changes observed based on standard DarT endpoints 
examined under a bright microscope (10 mg/L acetaminophen, 5 mg/L atenolol, 
4 mg/L atrazine, 0.5% ethanol and 5 mg/L lindane; Table 3.11) , the axon length 






Fig. 3.15 Lowest effective concentrations of neurotoxins for shortening of 
motoneuron axons. Chemical name and concentration are labeled at the left 








3.3 Tg (lfabf:DsRed; elaA:EGFP) (LiPan) for hepatotoxins screen 
3.3.1 Reduction of liver red fluorescence and size in LiPan transgenic fry 
by hepatotoxins 
To demonstrate the feasibility of using the LiPan transgenic fry for 
hepatotoxin assay, four well established hepatotoxins (acetaminophen, aspirin, 
isoniazid and phenylbutazone) were first tested. As exampled in Fig. 3.16, when 
LiPan embryos/fry were treated with 2.5 to 25 mg/L acetaminophen from 3 hpf 
to 120 hpf, there was a dosage-dependent reduction of red fluorescent intensity 
compared to the control group with 0.01% DMSO. There was no obvious 
developmental abnormality up to 10 mg/L. While at the highest dose (25 mg/L), 




Fig. 3.16. General phenotype and RFP and GFP expression in LiPan fry 
treated with example hepatotoxin acetaminophen. Representative fry from 
each treatment group with different concentrations are shown. (A) Vehicle 
control group with 0.01% DMSO. (B-F) Acetaminophen treatment groups with 
increasing concentrations of acetaminophen as indicated on the right. The left 
column represents general phenotype, the middle column shows liver-specific 
RFP and exocrine pancreas-specific GFP expression through a GFP filter (470 
nm wave length), and the right column is liver-specific RFP expression through 
an RFP filter (546 nm wave length). Note that edema in (F) was observed only 




 In the LiPan line, for each fry, under the RFP dark view, the same lateral view 
of the liver region of each fry was photographed with three images: one with 
auto exposure-time for the clearest view, one with fixed exposure-time to 
capture RFP intensity below saturation for intensity measurement and 
comparison, and the last one with sufficient exposure-time to show the whole 
liver region for size measurement. ImageJ software was then used to quantify 
RFP fluorescence intensity and liver size as we previously reported (Huang et 
al., 2012). Average RFP intensity in the liver was calculated and compared 
within the same group of lateral view fry under the same magnification and 
fixed exposure-time. 
Quantitative analyses of red fluorescence intensity confirmed the 
dosage-dependent reduction (Fig. 3.17A, Table 3.12) and statistically 
significant reduction of 8.9% was observed at the concentration of 5 mg/L and 
32% at 25 mg/L. 2D measurement of liver size as covered by the red 
fluorescence in the LiPan fry was also carried out and there was a similar 
reduction with the increase of acetaminophen concentration (Fig. 3.17A), and 
statistically significant reduction (13.0% and 18.0%) of liver size was observed 
at the concentrations of 20 and 25 mg/L, respectively. The GFP labeled exocrine 
pancreas also showed similar reduction in fluorescent intensity and the organ 




Fig. 3.17. Quantitative analyses of liver RFP intensity and liver size in 
LiPan fry treated with four established hepatotoxins. The four hepatotoxins 
used, acetaminophen, aspirin, isoniazid and phenylbutazone, are indicated at 
the top of each panel. At least eight larvae were analysed in each concentration 
group. Blue bars indicate liver RFP intensity and red bars refer liver size. 





Table 3.12 Summary of survival rates, hatching rates, lack of edema, liver RFP intensities and liver sizes in LiPan fry treated with 
various chemicals at different concentrations. Statistical analyses were carried out by t-test between treated and control groups: 
red highlights represent P<0.01 and yellow highlight 0.05.  
Chemicals Concentration Survival rate Hatching Lack of edema Liver RFP intensity 
 (% change) 
2D liver size (μm2) 
(% change) 
0.01% DMSO 0 mg/L 85.5% 85.5% 85.0% 876 (0) 32674 (0) 
Acetaminophen 
 
2.5 mg/L 84.5% 84.5% 84.5% 826 (-5.7) 31090 (-4.8) 
5 mg/L 82.5% 81.5% 81.0% 798 (-8.9) 30647 (-6.2) 
10 mg/L 71.0% 68.5% 67.5% 725 (-17.2) 29622 (-9.3) 
20 mg/L 64.0% 57.0% 59.5% 636 (-27.4) 28441 (-13) 
25 mg/L 53.0% 46.5% 48.5% 596 (-32.0) 26793 (-18) 
        
0.01% DMSO 0 mg/L 86.0% 86.0% 85.5% 840 (0) 31398 (0) 
Aspirin 
 
1 mg/L 84.5% 84.0% 84.5% 816 (-2.9) 30922 (-1.5) 
2.5 mg/L 81.5% 79.0% 80.5% 715 (-14.9) 30198 (-3.8) 
5 mg/L 76.0% 74.5% 74.0% 625 (-25.6) 30026 (-4.4) 
10 mg/L 70.5% 68.0% 66.5% 581 (-30.8) 28929 (-7.9) 
20 mg/L 58.5% 53.0% 54.5% 464 (-44.8) 26718 (-14.9) 
        
0.01% DMSO 0 mg/L 85.5% 85.5% 85.0% 820 (0) 31391 (0) 
Isoniazid 
 
1 mg/L 81.5% 80.5% 81.0% 786 (-4.1) 31597 (0.7) 
2.5 mg/L 76.0% 74.5% 75.0% 723 (-11.8) 30624 (-2.4) 
5 mg/L 70.5% 68.5% 67.0% 678 (-17.3) 29940 (-4.6) 
10 mg/L 64.5% 61.0% 59.0% 591 (-27.9) 28437 (-9.4) 
15 mg/L 57.5% 52.5% 51.0% 529 (-35.5) 27830 (-11.3) 
        





0.1 mg/L 82.0% 81.0% 81.5% 808 (-6.9) 31241 (0.4) 
0.25 mg/L 78.5% 77.5% 77.0% 762 (-12.2) 30357 (-2.5) 
0.5 mg/L 74.5% 73.0% 72.5% 667 (-23.2) 29668 (-4.7) 
0.8 mg/L 65.5% 61.0% 62.0% 537 (-38.1) 28027 (-9.9) 
1 mg/L 53.0% 49.0% 50.5% 511 (-41.1) 27368 (-12.1) 
        
0.01% DMSO 0 μg/L 87.5% 87.0% 87.5% 848 (0) 31931 (0) 
Mefenamic acid 
 
5 μg/L 81.0% 81.0% 79.5% 827 (-2.5) 30613 (-4.1) 
10 μg/L 75.5% 74.0% 74.5% 757 (-10.7) 29267 (-8.3) 
50 μg/L 71.0% 68.5% 66.0% 651 (-23.2) 26458 (-17.1) 
100 μg/L 57.5% 49.0% 51.0% 600 (-29.2) 24671 (-22.7) 
250 μg/L 40.5% 34.5% 35.5% 522 (-38.4) 21670 (-32.1) 
        
0.01% DMSO 0 mg/L 83.5% 83.5% 83.0% 857 (0) 31293 (0) 
Lindane 
 
1.25 mg/L 74.5% 72.5% 72.0% 847 (-1.2) 31942 (2.1) 
2.5 mg/L 68.5% 64.5% 63.5% 862 (0.6) 37284 (19.1) 
5 mg/L 56.5% 53.5% 55.5% 883 (3) 34671 (10.8) 
10 mg/L 48.0% 46.0% 46.5% 740 (-13.7) 31076 (-0.7) 
20 mg/L 33.5% 26.5% 29.0% 676 (-21.1) 28950 (-7.5) 
        
egg water 0 μg/L 86.0% 86.0% 86.0% 875 (0) 32755 (0) 
 
Arsenate  
10 μg/L 83.5% 83.0% 82.0% 862 (-1.5) 34257 (4.6) 
50 μg/L 79.0% 74.0% 74.5% 798 (-8.8) 32079 (-2.1) 
100 μg/L 70.5% 67.0% 66.0% 920 (5.1) 32322 (-1.3) 
250 μg/L 63.0% 58.5% 56.5% 928 (6.1) 36434 (11.2) 
500 μg/L 59.5% 51.5% 53.0% 722 (-17.5) 35863 (9.5) 
        
0.01% DMSO 0 μg/L 84.5% 84.5% 84.0% 833 (0) 27328 (0) 
17β-estradiol  1 μg/L 85.0% 84.0% 84.5% 880 (5.6) 29384 (7.5) 
5 μg/L 83.0% 83.0% 82.0% 957 (14.9) 31014 (13.5) 
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10 μg/L 81.5% 81.0% 81.5% 1060 (27.3) 32395 (18.5) 
50 μg/L 79.0% 77.0% 77.5% 1148 (37.8) 35800 (31) 
100 μg/L 76.5% 75.0% 73.5% 1257 (50.9) 40348 (47.6) 
        
0.01% DMSO 0 ng/L 85.5% 85.5% 85.0% 846 (0) 32851 (0) 
0.01% Toluene 0 ng/L 85.0% 84.5% 84.5% 837(-1.1) 31972(-2.7) 
TCDD 
 
100 ng/L 84.5% 84.5% 84.5% 821 (-3) 36381 (10.7) 
125 ng/L 81.5% 80.5% 81.0% 842 (-0.5) 37419 (13.9) 
250 ng/L 76.0% 73.5% 74.5% 830 (-1.9) 39867 (21.4) 
500 ng/L 71.5% 69.0% 67.5% 817 (-3.4) 41796 (27.2) 
1000 ng/L 64.0% 59.5% 60.5% 836 (-1.2) 46898 (42.8) 
        
0.01% DMSO 0 μg/L 86.5% 86.5% 86.5% 868 (0) 30473 (0) 
NDMA 
 
0.1 μg/L 87.5% 87.0% 87.0% 831 (-4.3) 38841 (27.5) 
1 μg/L 84.5% 84.5% 84.5% 843 (-2.9) 45055 (47.9) 
10 μg/L 82.0% 80.5% 81.5% 838 (-3.5) 51418 (68.7) 
25 μg/L 81.0% 78.5% 79.0% 872 (0.5) 50211 (64.8) 
100 μg/L 75.5% 74.5% 74.0% 807 (-7) 61059 (100.4) 
        
egg water 0 % 85.5% 85.0% 85.5% 853 (0) 31777 (0) 
Ethanol 
 
0.1 % 84.5% 84.5% 83.5% 846 (-0.8) 31846 (0.2) 
0.25 % 81.0% 80.0% 79.0% 878 (2.9) 31661 (-0.4) 
0.5 % 77.5% 74.0% 73.0% 859 (0.7) 29370 (-7.6) 
1 % 66.0% 57.5% 58.5% 882 (3.4) 28189 (-11.3) 
2 % 51.5% 40.5% 42.0% 903 (5.9) 27725 (-12.8) 
        
0.01% DMSO 0 mg/L 84.5% 84.0% 84.5% 815 (0) 31205 (0) 
Amoxicillin 
 
0.1 mg/L 83.0% 83.0% 83.0% 844 (3.6) 30988 (-0.7) 
0.5 mg/L 79.0% 76.5% 77.5% 820 (0.6) 30485 (-2.3) 
1 mg/L 72.0% 69.0% 71.0% 793 (-2.7) 32678 (4.7) 
97 
 
2 mg/L 65.5% 60.5% 57.5% 749 (-8.1) 30772 (-1.4) 
5 mg/L 52.5% 49.0% 47.5% 768 (-5.8) 29164 (-6.5) 
        
0.01% DMSO 0 mg/L 85.5% 85.5% 85.5% 811 (0) 31892 (0) 
Chlorphenamine 
 
0.1 mg/L 82.5% 82.5% 81.5% 829 (2.2) 32370 (1.5) 
0.5 mg/L 78.5% 78.0% 76.5% 845 (4.2) 30495 (-4.4) 
1 mg/L 74.0% 72.5% 69.5% 834 (2.8) 30131 (-5.5) 
1.5 mg/L 63.5% 60.5% 59.0% 801 (-1.2) 29611 (-7.2) 
2 mg/L 56.0% 51.5% 52.5% 787 (-3) 29285 (-8.2) 
        
0.01% DMSO 0  85.0% 84.5.0% 84.5% 903 (0) 33646 (0) 
Hepatotoxin mixture* 
 
1/16  85.5% 84.5.0% 84.0% 927 (2.6) 34114 (1.4) 
1/8  84.5% 83.0% 83.5% 886 (-1.9) 32150 (-4.4) 
1/4  81.0% 79% 79.5% 848 (-6.1) 31625 (-6.0) 
1/2  79.5% 74.0% 73.5% 763 (-15.5) 31149 (-7.4) 
1  74.5% 71.0% 71.5% 667(-26.1) 29863 (-11.2) 
* 1X hepatotoxins mixture contains 2.5 mg/L acetaminophen, 1 mg/L aspirin, 1 mg/L isoniazid and 0.1 mg/L phenylbutazone. 
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Similarly, LiPan embryos/fry were also treated with the three other 
hepatotoxins with a range of concentrations: 1-20 mg/L aspirin, 1-15 mg/L 
isoniazid and 0.1-1 mg/L phenylbutazone. As shown in Fig. 3.17B-D and Fig. 
3.18A-C, obvious dosage-dependent reduction of liver RFP intensity was 
observed in all of the three hypototoxin-treated groups with the statistical 
significance determined at ≥2.5 mg/L aspirin, ≥2.5 mg/L isoniazid and ≥0.25 
mg/L phenylbutazone. The maximal reduction of RFP fluorescence observed 
were 44.8%, 35.5% and 41.1% by 20 mg/L aspirin, 15 mg/L isoniazid and 1 
mg/L phenylbutazone respectively, which were higher than the maximal 
reduction observed from the highest acetaminophen concentration group. 
However, the change of liver size was not as obvious as the reduction of RFP 
intensity by these three hepatotoxins although there was a clear trend of 
reduction from all of the three groups. Statistically significant reduction was 
observed only from the highest concentration treatments for aspirin (20 mg/L) 
and phenylbutazone (1 mg/L) and the reduction was 15.9% and 12.1% 
respectively; however, there was no significant reduction of liver size measured 
from any concentration groups with the isoniazid treatment. Thus, it appears 






Fig. 3.18. Liver-specific RFP expression from representative fry treated 
with various chemicals at different concentrations. (A-L) Treatments with 
different chemicals as indicated on the right. Each column represents each 
chemical and concentrations are indicated within each panel. 0 indicates control 
groups with 0.01% DMSO except for the controls for arsenate and ethanol 




3.3.2 Hepatotoxicity tests for chemicals selected from different catagories 
To further evaluate the feasibility of using the LiPan embryos/fry to 
develop a convenient hepatotoxity assay, nine other chemicals of different 
categories were also selected for the LiPan zebrafish test. These chemicals 
include some well known environmental toxicants (lindane, arsenate, 
17β-estradiol, TCDD and NDMA), some widely used human drugs (mafenamic 
acid, cholorpheamine, and amoxicillin), and ethanol that is known to cause liver 
toxicity and damages at high concentration and extended exposure (Zhang et al., 
2003). Although the hepototoxic effects have been reported for some of these 
chemicals such as mafenamic acid, lindane and arsenate (Nadanaciva et al., 
2013; Patlolla et al., 2012; Radosavljevic et al., 2009b; Singh et al., 2011a; 
Somchit et al., 2004a; Zucchini-Pascal et al., 2011), generally their potential 
hepatotoxicity is not well documented.  
As shown in Fig. 3.19A and Fig. 3.18D, mefenamic acid was the only 
chemical to cause a clear dosage-dependent reduction of liver RFP fluorescence 
and liver size. A maximal reduction of RFP fluorescence intensity of 38.4% was 
observed in the highest concentration group (250 µg/L), which is comparable to 
the highest reduction observed from the four hepatotoxin treatments shown in 
Fig. 3.17. The reduction of liver size (up to 32.1%) was much more profound 
than those observed from the tests with the four hepatotoxins. Thus, based on 




Fig. 3.19. Quantitative analyses of liver RFP intensity and liver size in 
LiPan fry treated with nine chemicals. The names of the chemicals are 
indicated at the top of each panel. At least eight larvae were analysed in each 
concentration group. Blue bars indicate liver RFP intensity and red bars refer 




Other chemicals causing significant reduction of RFP fluorescence 
intensity in the liver included lindane (Fig. 3.19B, Fig. 3.18E) and arsenate (Fig. 
3.19C, Fig. 3.18F). However, the response with lindane was not strictly 
dosage-dependent and arsenate caused reduction (17.5%) was observed only in 
the highest concentration group (500 µg/L) (Table 3.12).  
The rest six chemicals did not cause observable reduction of RFP intensity 
in the liver. Instead there was an obvious dosage-dependent increase of RFP 
intensity in the liver by 17β-estradiol treatment, from 5.6% to 50.9% between 1 
and 100 µg/L 17β-estradiol; correspondingly there was a dosage dependent 
increase of liver size from 7.5% to 47.6% (Fig. 3.19D, Fig. 3.18G, Table 3.12). 
The observation was consistent with the role of estrogen in promoting cell 
proliferation (Okada et al., 2010) and our observation also suggested a role of 
estrogen in enhancement of hepatic activity. Similarly, both TCDD and NDMA 
treatments also showed increase of the liver size (Fig. 3.19E and 3.19F, Fig. 
3.18H and 3.18I, Table 3.12), consistent with their roles in promoting cell 
proliferation as both chemicals are considered to be carcinogens. The fact of 
lack of change of RFP intensity indicated that the two chemicals had no direct 
effects on haptic activity at the early stage of exposure. To confirm that there 
was an increased cell proliferation after treatments by 17β-estradiol, TCDD or 
NDMA. PCNA staining was performed on larvae treated by these three 
chemicals. Indeed there was an apparent increase of proliferating cells after 





Fig. 3.20. Increased hepatocyte proliferation induced by 17β-estrodiol (B), 
TCDD (C) and NDMA (D). Zebrafish larvae were treated 50 μg/L 
17β-estrodiol. 1000 ng/L TCDD or 100 μg/L NDMA from 3 dpf to 5 dpf and 
liver cryo-sections were prepared and stained by DAPI and PCNA. Increased 
numbers of proliferating hepatocytes were noted from 17β-estrodiol. TCDD 





Ethanol treatment showed small but statistically significant reductions 
(11.3% and 12.8%) of the liver size at the high concentrations (1% and 2%) (Fig. 
3.19G, Fig. 3.18J, Table 3.12). Combining with the observation of the lack of 
change of RFP intensity by ethanol, these observations suggest that the adverse 
effect of ethanol on liver function was not apparent in an acute exposure.  
The rest two chemicals, amoxicillin and chlorphenamine did not cause 
statistically significant change of neither the RFP intensity nor the liver size 
(Fig. 3.19H and 3.19I, Fig. 3.18K and 3.18L, Table 3.12), suggesting that their 
adverse role in liver function was not apparent. Consistent with this, their 
primary roles are not on the liver as amoxicillin is an antibiotic and 
chlorphenamine is a pain killer. 
3.3.3 Corresponding changes of endogenous fabp10a and other lipid 
pathway genes in response to hepatotoxic chemicals 
In the LiPan transgenic zebrafish, RFP expression is driven by the liver 
specific promoter fabp10a and thus the reduction of RFP intensity in response 
to hepatotoxins may reflect down-regulation of endogenous fabp10a gene 
which encode a fatty acid binding protein with functions in uptake and 
utilization of fatty acids as well as intracellular fatty acid transportation and 
metabolism (Storch et al., 2002). To confirm the down-regulation of fabp10a by 
hepatotoxic chemicals, both endogenous fabp10a and DsRed mRNAs were 
measured by RT-qPCR from whole fry samples treated with 10 mg/L 
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acetaminophen, 10 mg/L aspirin, 10 mg/L isoniazid, 1 mg/L phenylbutazone, 
100 µg/L mefenamic acid, 10 mg/L lindane, 500 μg/L arsenate, 50 µg/L 
17β-estradiol，1000 ng/L TCDD, 100 µg/L NDMA, 1% ethanol, 2 mg/L 
amoxicillin, and 2 mg/L chlorphenamine. As shown in Fig. 3.21, consistent 
with the observation on changes of DsRed fluorescence in the livers as shown in 
Figs 3.16-3.19, both fabp10a and DsRed mRNAs showed significant reduction 
in the four hepatotoxin treatment groups: acetaminophen, aspirin, isoniazid and 
phenylbutazone. Similarly, reduction of both fabp10a and DsRed mRNAs were 
also observed in the high concentration groups of mefenamic acid, lindane and 
arsenate treatment groups, where significant reduction of RFP fluorescence was 
observed (Fig. 3.19A to 3.19C). As positive and negative controls, both fabp10a 
and DsRed mRNAs were greatly increased in the 17β-estradiol, TCDD and 
NDMA-treated groups while there was no significant change of the two 
mRNAs in the last three treatment groups (ethanol, amoxicillin and 
chlorphenamine), again consistent with the data of RFP fluorescence in the liver 
in the two treatment groups (Fig. 3.19D to 3.19H). Thus, the change of RFP 
fluorescence we observed indeed reflects the level of endogenous fabp10a 





Fig. 3.21. Comparison of the mRNA levels of endogenous fabp10a and 
transgenic DsRed in LiPan fry treated with variable chemicals. 
Quantification was carried out by RT-qPCR. Bule bars represent fabp10a 
mRNA and red bars refer DsRed mRNA. Asterisks indicate statistical 






To examine whether there is a general effect on lipid pathway by 
hepatotoxins, four lipid pathway genes were selected for RT-qPCR 
measurements; they are apoa1 (apolipoprotein A-I), apobl (apolipoprotein B 
like), acox1 (acyl-Coenzyme A oxidase 1, palmitoyl) and apob (apolipoprotein 
B). As shown in Fig. 3.22, the expression of all of these four lipid pathway 
genes was significantly down-regulated by these proven hepatotoxins: 
acetaminophen, aspirin, isoniazid, phenylbutazone, mefenanmic acid, lindane 
and arsenate, while their expression was up-regulated by these chemicals 
causing increase of either the RFP intensity or the liver size or both: 
17β-estradiol, TCDD and NDMA. Similarly, another two liver specific genes, 
rbp2a (retinol binding protein 2a) and rbp2b (retinol binding protein 2b) were 
also similarly down- and up-regulated by these chemicals. Thus our 
quantitative gene expression assay demonstrated that there was a general 





Fig. 3.22. Expression of four lipid pathway genes (appa1, apobl, acox1, apob) 
and twp liver-specific genes (rbp2a, rbp2b) after chemical treatments. 
Chemical treatments were conducted from 3 hpf to 120 hpf and RT-qPCR was 
used to determine the level of gene expression. Numbers in the table are ΔΔCt 
value by using β-actin mRNA as internal control. Expression levels are 
represented by color gradients as indicated by the scale bar below, with the red 
color representing up-regulation and green color down-regulation. Gene names 
are indicated at the top and chemicals and their concentration used on the left. 




3.3.4 Detection of compound hepatotoxic effect from hapatotoxin mixture  
One important advantage of bioassay is the feasibility of analyzing 
biological effect from combined chemical mixture despite of undetectable 
levels of individual chemicals by chemical methods. To demonstrate the 
feasibility of using our haptotoxicity assay to test compound effect from a 
mixture of chemicals, the four established hepatotoxins (acetaminophen, aspirin, 
isoniazid and phenylbutazone) were mixed and used in exposure experiments. 
We first tested the mixture of four hepatotoxins at final concentrations just 
below their effective concentrations: 2.5 mg/L acetaminophen, 1 mg/L aspirin, 
1 mg/L isoniazid and 0.1 mg/L phenylbutazone, at which concentrations none 
of the hapatotoxins alone led to significant change of liver RFP intensity and 
liver size (Fig. 3.17). As shown in Fig. 3.23 and Table 3.12, a highly significant 
26.1% reduction of liver fluorescence intensity, accompanied with a significant 
11.2% reduction of liver size, was observed. Interestingly, when the test was 
carried out at a half of the concentration, a significant reduction (15.5%) of liver 
fluorescence intensity was still observed (Fig. 3.23, Table 3.12). In general, 
there was a dosage-dependent decrease of the hepatotoxic effect when the 
mixture was further diluted but the changes of both liver fluorescence intensity 
and liver size were not statistically significant after four fold dilution compared 






Fig. 3.23. Combined hepatotoxin effect. LiPan fry were treated with a mixture 
of four hepatotoxins with increasing dilution factors. “1” indicates undiluted 
mixture with the following final concentrations in the treatment: 2.5 mg/L 
acetaminophen, 1 mg/L aspirin, 1 mg/L isoniazid and 0.1 mg/L phenylbutazone. 
“0” represents vehicle control groups with 0.01% DMSO. All other groups are 
dilutions from ½ to 1/16. Blue bars indicate liver RFP intensity and red bars 
refer liver size. Representative liver-specific RFP expression is shown at top of 





3.4 Tg(lysC:DsRed2) for inflammation assay 
3.4.1 Pre-tests of six inorganic metallo-compounds with Tg(lysC:DsRed2)  
In the Tg(lysC:DsRed2) line, for each fry, under the RFP dark view, the 
same lateral view of the whole fry was photographed. Imaris software was used 
to count numbers of neutrophils. Average number of neutrophil from lateral 
view fry under the same magnification was determined. 
At first, we tested 6 heavy metals with the Tg(lysC:DsRed2) line, including 
mercury, chromium, copper, cadmium, zinc and lead. As shown in Fig. 3.24, all 
the six tested chemicals caused significant inflammation reaction in the fry body. 
As statistically analyzed in Fig. 3.25, the neutrophil number increased 
significantly after 300 µg/L Hg, 50 mg/L Cr, 100µg/L Cu, 200 µg/L Cd, 100 
µg/L Zn or 6 mg/L Pb treatment. Among them, except for 100 µg/L Zn 
treatment that fell into 95% confidence interval (p < 0.05), the other five metals 
all showed 99% confidence interval (p < 0.01). 
To validate the quantitative data, we choose two chemicals to perform the 
FACS assay, including Cd and Pb. As shown in Fig. 3.26, the Cd treated fry had 
more than 50% increased number of RFP labeled neutrophils [(1.12% - 0.741%) 
/ 0.741% = 51.1%], and the Pb treated fry had 22.1% increased number of 
neutrophils [(0.905% - 0.741%) / 0.741% = 22.1%]. These results are consistent 
with what we obtained from image analyses using Imaris software (31.3% 
increase in Cd treated fry and 19.1% increased in Pb treated fry). FACS assay 
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yielded higher percentage of increased neutrophils as the FACS assay counted 
all the RFP labeled cells in the fry body. In contrast, Imaris software analysis 
was based on 2D images counting; and the count maybe under-estimated due to 
overlapping signals from adjacent neutrophils. Nevertheless, the trend of 
increased neutrophils is quantitatively similar with both methods of 
measurement. The advantages of image analysis include requirement of a low 
number of fry in the assay, rapid in data collection and analysis, and feasibility 






Fig. 3.24. Inflammation tests for heavy metals in Tg(lysC:DsRed2). The left 
column shows general phenotype and the right column shows RFP-expressing 
neutrophils. (A) egg water control, (B) 300 μg/L Hg, (C) 50 mg/L Cr, (D) 100 
μg/L Cu, (E) 200 μg/L Cd, (F) 100 μg/L Zn, (G) 6 mg/L Pb. 
 
Fig. 3.25. Quantitation of neutrophil numbers in Tg(lysC:DsRed2) fry 
treated with different heavy metals. The chemical name and concentrations 
are indicated at the bottom of each column. At least five larvae were analyzed in 
each group. Blue bars indicate neutrophil number. Asterisks indicate statistical 



















































































































Fig. 3.26. FACS assay for quantification of increase of neutrophils in 
response to chemical treatment. Percentages of RFP labeled neutrophils out 
of all cells are indicated inside the diagrams. Left (control group), middle (Cd 




3.4.2 Further tests for selected environmental toxicants with 
Tg(lysC:DsRed2)  
As shown in Fig. 3.24, all the six metals tested caused significant 
inflammation reaction as indicated by significant increase of neutrophils. Next 
we would like to examine whether this inflammation assay would also be 
applicable to other environmental toxicants. Thus, we performed further tests 
for the following selected environmental toxicants of different categories: (1) 
endocrine disrupters, 17β-estradiol (E2) and Bisphenol-A (BPA); (2) organic 
nitrogen compounds, N-nitrosodiethylamine (NDEA) and 4-Nitrophenol; (3) 
organochlorine pesticides, γ-hexachlorocyclohexane (lindane); (4) polycyclic 
aromatic hydrocarbons (PAH), TCDD. For categories (1)-(3), we only tested 
one concentration for each related chemical, for categories (4), we tested 3 
concentrations on TCDD (1 nM, 5nM and 10 nM). 
As shown in Fig. 3.27 and Fig. 3.28, all of the tested chemicals from 
categories (1)-(3) showed significant increases of neutrophil number after 
treatment. Among all of them, especially E2, NDEA and 4-Nitrophenol, the fry 
showed significant inflammation reaction with increasing number of 
neutrophils, with p value less than 0.01. 
For TCDD treatment, as shown in Fig. 3.29 and 3.30, 1 nM TCDD did not 
cause a statistically significant change of neutrophil number; however, 5 nM 
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Fig. 3.27 Inflammation tests with various environmental toxicants in 
Tg(lysC:DsRed2). The left column shows general phenotype and the right 
column shows RFP-expressing neutrophils. (A) 0.01% DMSO control, (B) 2 
mg/L E2, (C) 5 mg/L BPA, (D) 100 mg/L NDEA, (E) 5 mg/L 4-Nitrophenol, (F) 
5 mg/L Lindane. 
 
 
Fig. 3.28. Quantitative analyses of neutrophil numbers in Tg(lysC:DsRed2) 
fry treated with different environmental toxicants. The chemical name and 
concentrations are indicated at the bottom of each column. At least five larvae 
were analyzed in each group. Blue bars indicate neutrophil number. Asterisks 
























































































Fig. 3.29. Inflammation test with TCDD in Tg(lysC:DsRed2). The left 
column shows general phenotype and the right column shows RFP-expressing 
neutrophils. (A) 0.01% DMSO control, (B) 1 nM TCDD, (C) 5 nM TCDD, (D) 
10 nM TCDD. 
 
 
Fig. 3.30. Quantitative analyses of neutrophils number in Tg(lysC:DsRed2) 
fry treated with different concentrations of TCDD. The concentrations are 
indicated at the bottom of each column. At least five larvae were analyzed in 
each group. Blue bars indicate neutrophil number. Asterisks indicate statistical 
significance: *, P<0.05; **, P<0.01. 
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3.4.3 Tests for neutrophil activator and inhibitor with Tg(lysC:DsRed2)  
  To validate the inflammation assay, we further tested neutrophil activator 
FPR-A14 (25 μM) and inhibitor PR-39 (50 nM). As shown in Fig. 3.31 and Fig. 
3.32, the 25 μM PFR-A14 treated group showed significantly increased number 
of neutrophils (p < 0.05). For the inflammation inhibitor PR-39-treated group, 






Fig. 3.31 Inflammation tests with neutrophil activator and inhibitor in 
Tg(lysC:DsRed2). The left column shows general phenotype and the right 
column shows RFP-expressing neutrophils. (A) 0.01% DMSO control, (B) 25 
μM FPR-A14, (C) 50 nM PR-39. 
 
 
Fig. 3.32. Quantitative analyses of neutrophils number in Tg(lysC:DsRed2) 
fry treated with neutrophil activator and inhibitor. The chemical name and 
concentrations are indicated at the bottom of each column. At least five larvae 
were analyzed in each group. Blue bars indicate neutrophil number. Asterisks 































































3.5 Water sample tests 
3.5.1 Test of settled raw sewerage water from Singapore 
The settled raw sewerage water (SRSW) was from a waste water treatment 
factory in Singapore. It was daily life waste water, not including the industrial 
waste water. Large particles had been settled down and thus the SRSW was just 
primary treated waste water. Live Paramecium were observed under a 
microscope in SRSW (data not shown). 
We tested the following transgenic zebrafish strains with SRSW: wild-type, 
Tg(nkx2.2a:mEGFP), Tg(krt8:EGFP; mylz2:DsRed), and Tg(lfabp:DsRed; 
elaA:EGFP) (LiPan). 
For wild-type zebrafish embryos test, as shown in Fig. 3.33, with increase of 
SRSW concentration or decrease of SRSW dilution, the 96 hpf survival rate, 72 
hpf hatching rate and 48 hpf heart-beat rate (15s) were decreased while 96 hpf 
edema rate increased. In Fig. 3.34, representative images of wild-type fry in 
different dilution of SRSW are shown. When the concentration of SRSW was 
above 25%, obvious abnormalities (curvature of the tail spine) were observed 
(around 18%). When the SRSW concentration was 50%, the fry also showed 
obvious delay in development. Undiluted SRSW was also tried; however, at 
around 3 dpf, after the fry hatched out, more than 80% fry died, and the survival 
ones could not live longer than 6 dpf. 
 When treated with SRSW (3.125%-50%) without feeding, wild-type fry in 
high concentrations died quickly at the beginning; however, the survival ones 
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could live longer (18 days) than control presumably because they could eat the 






Fig. 3.33 DarT endpoints of wild-type fry in the presence of different 
concentrations of SRSW. A. 96 hpf survival rates against different 
concentrations of the SRSW. B.72 hpf hatching rates against different 
concentrations of the SRSW. C. 96 hpf edema rates against different 
concentrations of the SRSW. D. 48 hpf heart rates (15s) against different 
concentrations of the SRSW.  
 
 
Fig. 3.34 Wild-type embryos with SRSW treatment (80+ hpf). At different 



























































 Using the Tg(nkx2.2a:mEGFP) line, as shown in Fig. 3.35, the average axon 
length showed concentration-dependent reduction. At 12.5% or higher dose, the 
reduction was statistically significant. These observations suggest the presence of 







Fig. 3.35 Tg(nkx2.2a:mEGFP) with SRSW treatment (96 hpf). A: General 
phenotypes (left column), GFP-expressing central nervous systems (middle 
column) and motoneuron axons (right column) of 96 hpf Tg(nkx2.2a:mEGFP) 
fry in different dilutions of SRSW as indicated on the right. B: Axon length 
measurement of Tg(nkx2.2a:mEGFP) after SRSW treatment. Blue bars indicate 




































 For Tg(krt8:EGFP;mylz2:DsRed), as shown in Fig. 3.36, when the SRSW 
concentration increased, the 72 hpf hatching rate decreased a lot for this line. As 
shown in Fig. 3.37, for all the tested SRSW concentrations, the skin GFP 
appeared to be normal under the GFP view; however, for muscle RFP 
expression, at 6.25% SRSW or higher dose, the intensity of muscle RFP showed 







Fig. 3.36 Tg(krt8:EGFP;mylz2:DsRed) fry in the presence of different 
concentrations of SRSW. A. 96 hpf survival rates against different 
concentrations of the SRSW. B.72 hpf hatching rates against different 
concentrations of the SRSW. C. 96 hpf edema rates against different 
concentrations of the SRSW. D. 48 hpf heart rates (15s) against different 
concentrations of the SRSW. 
 
Fig. 3.37 Tg(krt8:EGFP;mylz2:DsRed) with SRSW treatment (80+ hpf). 
Bright-field view (left column), GFP dark view for skin observation (middle 
column), RFP dark view for muscle observation (right column). Concentrations 


























































 For the LiPan line, as shown in Fig. 3.38, the 72 hpf hatchingare rate decreased 
when the SRSW concentration was 25%, and edema rate was also increased at 
this concentration. In Fig. 3.39, when the dose was 1/16 (6.25%), the liver size 
became smaller, and when the dose reached 1/4, the liver size was even much 








Fig. 3.38 LiPan fry in the presence of different concentrations of SRSW. A. 
96 hpf survival rates against different concentrations of the SRSW. B.72 hpf 
hatching rates against different concentrations of the SRSW. C. 96 hpf edema 
rates against different concentrations of the SRSW. D. 48 hpf heart rates (15s) 
against different concentrations of the SRSW. 
 
 
Fig. 3.39. The LiPan with SRSW treatment (80+ hpf). Bright-field view (left 
column), GFP dark view for liver (yellow) and pancreas observation (middle 
column), RFP dark view for liver observation (right column). Concentrations 






























































 In sum, as shown in Fig. 3.35, SRSW shortened axon length, indicating the 
presence of neurotoxins. SRSW also down-regulated the muscle RFP 
expression, but had little effect on the skin GFP (Fig. 3.37); Finally, SRSW 
down-regulated both liver RFP and pancreas GFP expression, suggesting 
toxicity to both organs (Fig. 3.39) . 
 
3.5.2 Test of secondary effluent water from USA 
  Water sample was obtained from Professor Shane Snyder of University of 
Arizona, USA. This water sample was secondary effluent from the Roger Road 
Waste Water Treatment Plant (RRWWTP) (Tucson, Arizona, USA) and it is 
usually directly discharged into the environment, forming a small water stream 
on its own. We received the water sample as 10,000x concentration in DMSO. 
  The concentrated RRWWTP water sample was diluted into five concentration 
groups using Egg Water (60 mg/L of commercial Sea Salt dissolved in distilled 
water for optimal fish growth): the original concentration (1x), two higher 
concentrations (2.5x and 5x) and two lower concentration (0.2x and 0.5x). 
Control water used was 0.1% DMSO in Egg Water, yielding a total of six 
groups. This water sample was tested in the Tg(nkx2.2a:mEGFP). 
Well-developing embryos at 3 hpf were transferred to 6-well plates for assay, 
with 40 or 50 embryos per group in 10 mL of respective solutions. Water was 
changed daily and observation was made at 8 hpf, 24 hpf, 48 hpf, 72 hpf and 96 
hpf. At 96 hpf, fluorescent images were taken for 5-10 fish/group, following 
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which axon lengths and fluorescent intensities were measured using the open 
software ImageJ. 
As shown in Fig. 3.40, for all the concentrations tested, the morphology of 
fry under bright-field view seemed to be normal. For axon length endpoint, 
under the dose 0.2x, the fry did not show statistically significant reduction of 
axon length. However, from 0.5x and above, the axon length of fry significantly 







Fig. 3.40 Tg(nkx2.2a:mEGFP) with Roger Road secondary effluent 
treatment (96 hpf). A: General phenotypes (left column), GFP-expressing 
central nervous systems (middle column) and motoneuron axons (right column) 
of 96 hpf Tg(nkx2.2a:mEGFP) fry in different concentrations of RRWWTP 
water sample as indicated on the right. B: Axon length measurement of 
Tg(nkx2.2a:mEGFP) after RRWWTP water sample treatment. Blue bars 
indicate axon length. Asterisks indicate statistical significance: **. P<0.01. 
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4. Discussion  
4.1 FT-DarT tests and comparison with DarT 
  As summarized in Table 3.10, I have tested a total of 24 environmental 
chemicals in 9 different fluorescent transgenic zebrafish lines.  
All of these chemicals choose are popular environmental toxicants found in 
water. They represent many different categories, including pharmaceuticals & 
personal care products (PPCPs), endocrine disrupting compounds (EDCs), 
persistent organic compounds (POPs), organic-nitro-compound and 
metalized-compound. For each different assay, some previously characterized 
specific toxicants and other potential chemicals were chosen. For instance, in 
the hepatotoxin assay, among the 13 chemicals chosen, four of them are well 
known hepatotoxins. 
When compared the data obtained in parallel with the wild-type DarT tests, 
for each chemical (except for chlorphenamine and amoxicillin), there is at least 
one transgenic line showed improvement of testing sensitivity. Thus we 
demonstrated that indeed fluorescent transgenic zebrafish provide a more 
sensitive tool for analyzing chemical-induced teratogenic changes. Furthermore, 
we also developed several specific toxicity assays using a few specific 
fluorescent transgenic lines, including neurotoxicity assay using 
Tg(nkx2.2a:mEGFP), hepatotoxicity assay using the LiPan line 
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Tg(lfabp10a:DsRed;elaA:EGFP), and inflammation assay using 
Tg(lysC:DsRed2), with detail in section 4.2 - 4.4. 
For Tg(nkx2.2a:mEGFP), as shown in the section 3.2, neurotoxins could 
be screened by this fluorescent transgenic line, and it is 5-10 fold more sensitive 
than the wild-type DarT tests. The detail for the mechanisms of the chemical 
toxicity reaction mode is in section 4.2. 
In Tg(ﬂi1:EGFP) fry, after 17β-estradiol treatment, the GFP intensity of 
intersegmental blood vessel was decreased dose-dependently. Previously, a 
study about the effect of estrogen on the blood vessel wall has indicated rapid 
vasodilatory effect and atheroprotective effect involving inhibition of 
smooth-muscle cell proliferation (Mendelsohn and Karas, 1994). Another study 
has shown that both endothelial cells and vascular smooth muscle cells possess 
estrogen receptors and they are physiological targets for estrogen action (Koh, 
2002). Estrogen stimulates the constitutive synthesis of NO (nitric oxide) in 
numerous tissues, including blood vessels, heart, uterus, and skeletal muscle. 
Reduction in vessel wall concentration of oxidized LDL (low-density 
lipoprotein) may improve NO synthesis, release, and biological activity (Koh, 
2002). Thus, this Tg(ﬂi1:EGFP) line could be useful for tests of cardiovascular 
toxicants. 
In Tg(krt8:EGFP) fry, after arsenate treatment, the skin GFP intensity 
significantly increased. There is a long history of studies about arsenic toxicity 
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on skin. For example, arsenic dust coming into contact with the skin produces 
four main types of reactions: toxic, eczematous, combined toxic and 
eczematous, and follicular lesions (Holmqvist, 1951). Skin lesions are common 
in patients with acute arsenic poisoning. Based on review of the literature, 
within a few days of the poisoning, transient flushing of the skin on the face, 
trunk or extremities and facial edema may appear, particularly on the eyelids, 
and also conjunctival haemorrhage. (Bartolome et al., 1999; Uede and 
Furukawa, 2003). Therefore, this transgenic line might be applied for skin 
toxicant screening. 
The double transgenic line Tg(krt8:EGFP; mylz2:DsRed), after arsenate 
treatment, showed consistent result as Tg(krt8:EGFP) line with increased GFP 
intensity of skin. For the muscle RFP, only mefenamic acid treated group 
showed decreased RFP intensity. Mefenamic acid is a nonsteroidal 
anti-inflammatory drug and is often used as a pain-killer. In smooth muscle, 
mefenamic acid has been shown to activate K
+
 currents, which are 
Ca
2+
-independent delayed rectified currents (Farrugia et al., 1993). Mefenamic 
acid increases the channel activities of two distinct types of K
+ 
channels (i.e. 
BKCa channels and KATP channels) and decreased 4-aminopyridine-sensitive 
K
+
 channels in pig urethral myocytes (Teramoto et al., 2003). In rabbit portal 
vein, mefenamic acid inhibits spontaneous transient inward currents (STICs) 
and spontaneous transient outward currents (STOCs) in a 
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concentration-dependent manner (Greenwood and Large, 1995). There are case 
reports showed that one side effect of mefenamic acid is to cause muscle pain 
(http://www.ehealthme.com/ds/mefenamic+acid/muscle+pain). To sum up, this 
double transgenic line could be useful for both skin and muscle toxicity tests. 
For the Tg(lfabf:DsRed; elaA:EGFP) LiPan line, most hepatotoxins could 
be screened by it. In section 4.3, the details of different hepatotoxins reaction 
modes are revealed.  
Only lindane was tested in the Tg(ins:gfp) line, and the islet size had dose 
dependent decrease. The pancreas is an important organ of the digestive 
system and endocrine system of vertebrates. Islets of the pancreas are the 
tissues with an endocrine role, which secret hormones, such as insulin, 
glucagon and somatostatin. As early in 1976, Zakirov UB et al have studied the 
disordered function of the pancreas under the effect of different doses of 
hexachlorocyclohexane (lindane). The experiments have been conducted on 
albino rats and the results have indicated that lindane is capable of inhibiting the 
secretion of the amylase, lipase, and proteases of the pancreas (Zakirov et al., 
1976). Another study with fish (European eel) has shown that after exposure to 
lindane, the fish carbohydrate metabolism is affected, and this may be related 
to the insulin regulation disorder (Ferrando and Andreu-Moliner, 1991). Thus, 
the Tg(ins:gfp) line might be useful for pancreas toxicity screening.  
For Tg(gata1:dsRED) line, no significant improvement were found 
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compared with wild-type DarT after atenolol, 17β-estradiol or lindane treatment. 
This could be due to our current image-based analytical protocol, where we 
capture the image with a relative long exposure time and could not distinguish 
single blood cell, instead only to obtain a rapid flow of the blood cells under the 
dark-field RFP view. Thus, this fluorescent transgenic line may not be suitable 
for toxicity test in the current setting in image collection and analysis. However, 
if we take video of this line, it might be useful for cardiovascular toxicity tests, 
as the blood flow rate might be affected by different chemicals treatments. 
 ET10 line is an enhancer trap line with GFP expression in multiple 
regions, including the mantle cells of neuromasts of the lateral line, branchial 
arches, tendons, a subset of interneurons in the dorsal spinal cord, pronephros 
and olfactory pits. Only lindane was tested with this transgenic line and 
irregular shape of mantle cells of the lateral line was observed. The fish lateral 
line is a system of sense organs and serves an important role in normal 
swimming pattern and balance of fish body. There is no direct evidence to show 
that the insecticide may change the shape of mantle cell; however, there was a 
study indicating that DDT (dichlorodiphenyltrichloroethane) may affect the 
swim pattern of fish by affecting the lateral line. Pesticides may act on either 
peripheral or central (or both) nervous structures to cause behavior changes in 
fish. One receptor system (the lateral line) was markedly affected by sublethal 
concentrations of DDT (Anderson and Peterson, 1969). Similarly, as shown in 
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results section, after a high dose of lindane treatment, the fry also showed 
behavior change, with coiled body and spiral-locally swimming pattern. This 
may be due to the morphological and functional changes of lateral line. 
However, this ET line may not improve the test sensitivity much compared with 
wild-type DarT endpoint. 
The last line we tesed, Tg(lysC:DsRed2), can be employed as a rapid 
testing model for inflammation reactions caused by a wide range of chemicals. 
Detailed mechanisms and mode of reactions are discussed in section 4.4. 
4.2 Tg(nkx2.2a: GFP) for neurotoxicity assay 
 In the present study, we demonstrated that the fluorescent transgenic 
zebrafish Tg(nkx2.2a:mEGFP), in which the central nervous system including 
trunk axons is marked by GFP expression under the nkz2.2a promoter (Ng et al., 
2005; Pauls et al., 2007), can be used as a highly sensitive system for testing 
neurotoxins, thus providing a rapid and convenient assay to screen for 
neurotoxins. Recently, Fan et al (Fan et al., 2010) also proposed to use a 
quantitative RT-PCR based assay to analyse expression of a few selected neural 
developmental marker genes in early zebrafish embryos for screening of 
neurotoxins and nkx2.2a is one of the markers selected. Compared to the 
quantitative RT-PCR assay, the current fluorescent transgenic assay has directly 
observable and measureable phenotypes in live fry and thus is convenient and 
rapid. Furthermore, the fluorescent transgenic zebrafish has the potential to 
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develop to a high-throughput assay with possible automation (Gehrig et al., 
2009; Vogt et al., 2009),  
In this study, six chemicals with a range of dosages were tested in zebrafish 
embryos/larvae, including acetaminophen, atenolol, atrazine, ethanol, lindane 
and mefenamic acid. While two of them, ethanol (Sylvain et al., 2010) and 
lindane (Gustafsson et al., 2010), are widely considered to be neurotoxins at 
high dose, three are candidate neurotoxins: acetaminophen (David and 
Pancharatna, 2009; Posadas et al., 2010), atenolol (Teixeira et al., 2005) and 
atrazine (Belloni et al., 2011; Giusi et al., 2010; Ton et al., 2006). The last one, 
mefenamic acid, is considered to be neuroprotectant (Khansari and Halliwell, 
2009). The five neurotoxins have different molecular modes of action. 
Acetaminophen is a popular drug for treatment of headache and it is available 
over the counter; its mode of action is not completely understood, but its main 
mechanism appears to be the inhibition of cycloxygenase (COX) and it is highly 
selective for COX-2 (Hinz et al., 2008). Atenolol is a β1-adrenoceptor 
antagonists and its molecular mechanism includes blockade of voltage-gated 
sodium channels. Atrazine is a herbicide widely used in agriculture activities 
and it disrupts the photosystem II in plants by binding to the 
plastoquinone-binding protein (Varadi et al., 2003). It does produce a 
teratogenic effect in fish (such as reduction of the tail fin) (David and 
Pancharatna, 2009; Giusi et al., 2010). Ethanol is a well known neurontoxin at 
141 
 
high dosage through binding to acetylcholine, GABA (gamma-aminobutyric 
acid), serotonin, and NMDA (N-Methyl-D-aspartate) receptors (Heaton et al., 
2000a; Heaton et al., 2000b; Kennedy and Mukerji, 1986). Lindane is an 
organochlorine chemical used as an agricultural insecticide and it interferes 
with GABA neurotransmitter by interacting with the GABA receptor-chloride 
channel complex at the picrotoxin binding site (Maskell et al., 2001). 
Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, 
such as menstrual pain and its mode of action appears to be inhibition of 
prostaglandin synthesis (Hegazy and Ali, 2012; Joo et al., 2006). 
For the five neurotoxins, many studies have been conducted in experimental 
animals and their toxicity in the nervous system has been documented. 
Acetaminophen has also been previously tested in zebrafish and its general 
effect on embryonic development, nephrotoxicity and hepatotoxicity have been 
reported (David and Pancharatna, 2009; Peng et al., 2010; Weigt et al., 2010), 
but its neurotoxicity has not been studied. Its direct neurotoxic action has been 
recently established by both in vitro and in vivo studies in rats and neuronal 
apoptosis has been observed at concentration of 1-2 mM (150-300 mg/L) 
(Posadas et al., 2010). Apparently the zebrafish larvae are more sensitive to 
acetaminophen as significant embryonic developmental defects were observed 
at concentration of 10 mg/L while significant shortening of axon length 
occurred at concentration as low as 2 mg/L. Atenolol may cause an allosteric 
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inhibition of voltage-gated sodium channels and blockade of neural nitric oxide 
release, as reported from a study in rabbit (Teixeira et al., 2005). Another study 
in mice shows that atenolol disrupt the positive feedback to the central nervous 
system and results in a decreased locomotor activity and background contextual 
fear (Janitzky et al., 2007). Atrazine has been tested in zebrafish for 
developmental neurotoxicity and it increases cell death in brain and causes 
disorganized motor neuron axon growth (Ton et al., 2006). Consistent with this, 
a mouse study has also indicated that early exposure to low doses of atrazine 
affects the mice behavior related to neurodevelopmental disorder (Belloni et al., 
2011). Alcohol abuse and its neurotoxic effect in human have been well 
demonstrated and alcohol also causes progressive neuroinflammation and 
neurological disorder (Haorah et al., 2008). In zebrafish, it has been reported 
that ethanol causes abnormal development of motor neurons and muscle ﬁbers 
(Sylvain et al., 2010). The neurotoxic effect of lindane has also been well 
documented (Gustafsson et al., 2010; Johri et al., 2008) and chronic exposure of 
low dose of lindane causes neurobehavioral, neurochemical, and 
electrophysiologrcal efects in rat brain (Anand et al., 1998).  
Our observations in the present study are consistent with the general mode of 
the action of these six chemicals. All of the five neurotoxins, acetaminophen, 
atenolol, atrazine, ethanol and lindane, showed sensitive inhibition of axon 
growth. In contrast, mefenamic acid has a significant neuroprotective effect by 
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inhibition of glutamate-induced cell toxicity in vitro and reduces ischemic 
stroke in vivo in rats (Khansari and Halliwell, 2009). Our observation is also 
consistent with its neural protectant role as the toxic concentrations (10 and 50 
µg/L) of mefenamic acid, which caused statistically highly significant edema, 
light pigmentation and shorter body length, apparently had no effect on the axon 
growth.  
It is apparent that all of these six chemicals show dosage-dependent toxicity 
in essentially all the endpoints analysed (Table 3.11). In the present study, we 
demonstrated that, compared to the recommended DarT endpoints, axon length, 
which can be observed and measured in Tg(nkx2.2a:mEGFP) fry, is about 10 
fold more sensitive than the most sensitive endpoints recommended in DarT. 
Thus, with the ease and direct observable features of GFP expression, the 
Tg(nkx2.2a:mEGFP) transgenic zebrafish provides a convenient and highly 
sensitive tool for screening and testing neurotoxic compounds, which will be 
applicable in environmental monitoring and pharmaceutical tests. 
4.3 The LiPan for hepatotoxicity assay 
 Based on an extensive analysis of hepatic transcriptomic data obtained 
from zebrafish treated with various environmental chemicals, we have 
previously reported the existence of an inverted profile of two hub biological 
pathways in response to chemical perturbations (Ung et al., 2011). One set was 
primarily associated with lipid metabolism while the other set was non-lipid 
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pathways. Up-regulation of several lipid-related pathways are generally 
accompanied with down-regulation of the other set of non-lipid pathways, or 
vice versa (Ung et al., 2011). Since change in lipid metabolism is often an 
important feature during chemical perturbation, expression of fabp10a, which 
codes for a liver fatty acid binding protein, is likely a valid marker of 
chemical-induced hepatotoxicity as reflected by liver RFP intensity in LiPan 
transgenic zebrafish. This observation was further supported by RT-qPCR 
measurement of the expression of four other lipd pathway related genes (Fig. 
3.22). For chemicals that exert toxicity via a lipid independent mechanism, RFP 
fluorescence in LiPan fry also facilitates the observation and measurement of 
the liver size which may be altered when there is a severe effect on liver or when 
the chemicals induce hypertrophy or atrophy.  
In the present study, we first demonstrated with four well established 
hepatotoxins that both liver RFP intensity and the liver size in LiPan fry were 
significantly reduced by the four hepatotoxins. As negative controls, neither 
chlorphenamine nor amoxicillin significantly alter RFP intensity and liver size 
in LiPan fry even at concentrations that increased edema rate or reduced 
hatching rate. This is not surprising since both drugs are not considered to be 
hepactotoxins. Chlorphenamine is an antihistamine and is used to relieve 
allergic conditions (Minigh, 2008) while amoxicillin is an antibiotics although 
it may cause cholestasis when it is co-administered with clavulanate 
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(Zimmerman, 2000). In contrast, the rest seven chemicals tested caused the 
changes of either liver RFP intensity or liver size, or both. Some of these drugs 
have been previously reported to incur liver injury while there is no information 
for many others regarding their potential hepatotoxicity.  
In addition to the four positive control hepatotoxins (acetaminophen, 
aspirin, isoniazid and phenylbutazone), mefenamic acid also caused decrease of 
both liver RFP intensity and liver size. Aspirin, phenylbutazone and mefenamic 
acid are non-steroidal anti-inflammatory drugs (NSAIDs), a major class of 
analgesics characterized by their inhibitory effects on cyclooxygenase (COX) 
enzymes and the second most common cause of drug induced liver injury 
(Hussaini, 2007; Katz, 2005). The COX enzyme system converts arachidonic 
acid to cyclic endoperoxide prostaglandin G2, which is further processed by 
other enzymes to form various prostaglandins, mediators of pain transmission. 
Mechanisms of hepatotoxicity of NSAIDs are not yet clear and they may be 
class-specific but COX-2 inhibition has been shown to be associated with 
hepatotoxicity. (Aithal, 2011; Hussaini, 2007). To date, 21 NSAIDs in the 
market have been reported to cause chronic liver injury or acute idiosyncratic 
liver damages, among which aspirin accounts for 12% of the total cases 
(Agúndez et al., 2011). Phenylbutazone was introduced in 1949 to treat 
rheumatoid arthritis but removed from the market in many countries since 1983 
due to its toxicity to multiple organs including liver. It is now mainly used in 
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horses with reduced dosage. Although the hepatotoxicity of phenylbutazone is 
well documented, its mechanism is poorly understood, partly due to the lack of 
studies after its withdrawal (Aronson, 2008; Soma et al., 2012). Mefenamic acid 
is not generally considered as a hepatotoxin, as there has been only one 
published case of severe but non-fatal hepatic necrosis (Lewis, 2007). A 14-day 
study in mice, with a relatively high dose of 50 mg/kg/day and 100 mg/kg/day, 
suggested that mefenamic acid could lead to hepatocellular necrosis, 
degeneration and inflammation (Somchit et al., 2004b). Our current assay 
demonstrated the potential of mefenamic acid causing liver damage within 5 
days in larvae. The relation between FABP (fatty acid binding protein) 
abundance and COX enzyme inhibition has not been reported; the reduction of 
RFP intensity observed in these three NSAID treated groups could be a result of 
either direct perturbation of fatty acids metabolism pathway or a secondary 
effect of server liver damage with reduced liver size.  
In addition, both lindane and arsenate treatments showed clearly the 
reduction of liver RFP intensity at high concentrations used in the present study 
but the change in the liver size was not significant. Arsenate has been found to 
alter lipid metabolism (Cheng et al., 2011) and to reduce the mRNA of a 
adipocyte fatty acid binding protein (aP2) during in vitro adipogenesis (Wauson 
et al., 2002), consistent with our current findings. Interestingly, in an adult 
zebrafish acute exposure set-up, fatty acid binding proteins have been found to 
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be up-regulated by arsenate in male fish but not female fish (Carlson et al., 
2013). It may suggest that the effect of arsenate on lipid metabolism is 
sex-dependent; however, our embryo assay evaluates toxicity without 
discrimination of sexes. Lindane, a persistent organochlorinated pesticide with 
main adverse effects in nervous system, has been reported to cause liver injury 
and fatty infiltration to liver (Mrema et al., 2013; Nolan et al., 2012; 
Radosavljevic et al., 2009a). The toxicity is believed to be at least partly due to 
induction of oxidative stress (Nolan et al., 2012; Radosavljevic et al., 2009a). 
However, there are no clear associations between lindane and fatty acid binding 
proteins, except that several studies have indicated association between lindane 
intake and altered lipid composition (Nolan et al., 2012; Radosavljevic et al., 
2009a), lipogenic enzymes (Boll et al., 1995) or lipid peroxidation (Vijaya 
Padma et al., 2011). In contrast, ethanol is known to cause fatty liver toxicity 
(Zhang et al., 2003) but we did not detect a significant change of liver RFP 
intensity in the acute exposure and its effect on the liver could be more 
prominent on chronic exposure. Nevertheless, we observed that acute ethanol 
treatment resulted in marked reduction of liver size when the treatment 
concentration was 1% or higher.  
Estrogens and functional estrogen receptors have been shown to have 
protective effect against high fat-diet induced obesity and fatty liver in a few 
animal studies (Hewitt et al., 2004; Ohlsson et al., 2000; Zhang et al., 2013). It 
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is thus interesting to note that estradiol treatment led to significant increase of 
both liver RFP intensity and liver size, which may indicate enhancement of liver 
function. Similarly, both TCDD and NDMA also caused liver enlargement but 
not an increase of liver RFP intensity. Consistent with the observation, both 
TCDD and NDMA are classified as carcinogens by IARC (The International 
Agency for Research on Cancer). TCDD is an IARC Group 1 carcinogen that 
has been shown to promote liver tumour formation in various animal models 
(Knerr and Schrenk, 2006). NDMA is a “probable carcinogen” (Group 2A) and 
it is found to be positively associated with cancer formation in various animal 
models (Richardson et al., 2007), including the zebrafish (Mizgireuv et al., 
2004). While TCDD caused significant liver enlargement only at a relatively 
high concentration of 125 ng/L with accompanying reduction in hatching rate, 
NDMA affected liver size from 1 μg/L onwards while there was no noticeable 
changes in gross appearance based on conventional toxicological endpoints 
such as DarT (Nagel, 2002a), 
Serum LFABP (liver fatty acid binding protein) has been used as a 
biomarker for screening acute kidney damage for years (Vanmassenhove et al., 
2013). Decreased LFABP has been found to be a hepatocellular adenoma 
marker specific to a subtype HNF1α mutation (Bioulac-Sage et al., 2008), 
similar to our earlier observation in carcinogen-induced liver tumors in 
zebrafish (Lam and Gong, 2006; Lam et al., 2006). Here we reported that both 
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lfabp10a (or lfabp) mRNA and RFP intensity in the LiPan fry sensitively 
reflected chemical-induced liver toxicity. As shown in Fig. 3.19 and Fig. 3.21, 
most changes in RFP intensity and liver size are within one fold, while changes 
in the level of fabp10a mRNA were generally greater than two fold. The smaller 
fold change at protein level than its mRNA level is commonly observed when 
protein and RNA data are compared (Jayapal et al., 2008; Le Roch et al., 2004; 
Maier et al., 2009). The greater fold change at transcript level indicates that 
mRNA quantification is a more sensitive measurement due to its greater range 
of detection. Nonetheless, direct visualization of RFP fluorescence is 
convenient and can be performed in live specimen repeatedly for multiple 
time-points. Furthermore, RFP fluorescence also reveals liver morphological 
change that is not possibly available from mRNA measurement.  
4.4 Tg(lysC:DsRed2) for inflammation assay 
Inflammation is now recognized as a major factor in the pathogenesis of 
many chronic diseases, such as atherosclerosis, metabolic disorders, cancers, 
and diabetes (Moore and Tabas, 2011; Tsimikas and Miller, 2011). Extensive 
research in the past few decades has revealed the mechanism of chronic 
inflammation, which caused by continued oxidative stress. The reason is that 
oxidative stress can activate a variety of related transcription factors, including 
NF-κB, AP-1, p53, HIF-1α, PPAR-γ, β-catenin/Wnt, and Nrf2. The activation 
of these transcription factors will further lead to the expression of more than 500 
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different genes, which related to growth factors, inflammatory cytokines, 
chemokines, and cell cycle regulatory molecules (Reuter et al., 2010). Thus, to 
develop a convenient inflammation assay by using a fluorescent transgenic 
zebrafish model is of crucial importance.  
In 2010, d'Alençon et al have published an inflammation assay in zebrafish, 
in which the inflammation can be assayed in real time using transgenic 
zebrafish expressing fluorescent proteins in leukocytes or by histochemical 
assays in fixed larvae. The leukocyte RFP line used was Tg(lysC:DsRed2) 
(d'Alencon et al., 2010). This transgenic line was also available in our 
laboratory, thus, we tested a broad range of environmental toxicants as 
described in results 3.4. 
In the original assay developed by d'Alençon et al, they measured the 
inflammation by manual counting of neutrophil number in 3 dpf larva in a 
specific small area. They chose a fixed area of the horizontal myoseptum, and 
that area was of approximately 10 cell diameters. Leukocytes in this correspond 
area of each fry were manually counted. For all the tested groups, leukocytes 
number in that area was statistically analyzed by this manually counting 
quantification. (d'Alencon et al., 2010). 
In our tests, we developed new measurement methods by using the 
software Imaris. By using this software, we can fix the threshold and measure 
the neutrophil number throughout the whole fry body, thus providing a more 
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complete, unbiased measurement of inflammation response in zebrafish fry. 
The accountability of the quantitative assay was further validated by FACS 
assay, which counting the neutrophil percentage out of the whole fry. Although 
the Imaris-based quantification has mitigated the changes in number of 
neutrophils compared to the FACS-based quantification, the trend of 
inflammation response measured by both methods are quantitatively consistent. 
The only difference is that by FACS assay, the increasing percentage of 
neutrophil number was higher than the counting by Imaris. For example, as 
shown in the results part, we choose Cd and Pb to perform the FACS assay, the 
Cd treated fry had more than 50% increased number of RFP labeled neutrophils, 
and the Pb treated fry had 22.1% increased number of neutrophils, while by 
image analyses using Imaris software, only 31.3% increase in Cd treated fry and 
19.1% increased in Pb treated fry. The reason is that the FACS assay counts all 
cells of the entire fry body, while the Imaris only counts based on 2D images. 
However, the 2D image counting by Imaris software is rapid and more 
convenient for developing high-throughput assay than the FACS assay. 
Using Tg(lysC:DsRed2), we tested a total of 12 common environmental 
toxicants which belong to several major categories, including inorganic 
metallo-compounds (6): mercury, chromium, copper, cadmium, zinc and lead; 
polycyclic aromatic hydrocarbons (PAH) (1): TCDD; endocrine disrupters (2): 
E2 and BPA; organic nitrogen compounds (2): NDEA and 4-Nitrophenol, and 
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organochlorine pesticides (1): lindane.  
For all the 12 chemicals tested, except for TCDD, all (up to relatively high 
dose) caused some degree of inflammation response or increase of neutrophil 
number with statistical significance.  
The inflammation caused by heavy metals is consistent with several 
previous reports. Primary mechanisms of metal toxicity involve the production 
of free radicals, which can trigger oxidative stress, and further induce 
mutagenesis by DNA-metal interactions, impair protein function by covalently 
modifying proteins or competing with metal binding sites (Simmons et al., 
2009). Metal-derived reactive oxygen species (ROS) may perturb a number of 
tightly regulated cellular processes (e.g., cell growth and proliferation), activate 
transcription factors and genes, and trigger cellular adaptive programs including 
metal stress response, DNA repair mechanisms, and inflammation 
(Hussainzada et al., 2014). In addition to the toxic effects of high level of ROS, 
the intracellular production of ROS is intimately involved in the regulation of 
normal cellular function and in inflammatory responses (D'Autreaux and 
Toledano, 2007). For instance, chromium poisoning caused visible changes in 
fish behavior and general appearance, including sluggish swimming, gasping 
and ulcerations near the tail in some fish. Exposure to chromium 
histopathologically affected the gills, intestine, and pharynx. Both gill and 
pharynx epithelium exhibited mononuclear cell infiltration, which is indicative 
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of acute inflammation (Mishra and Mohanty, 2009). Genes associated with 
inflammation ( such as pcna, nfkbiaa, hamp2, ptgs2a, ptgs2b, ptges, 
dusp2, dusp5 and dusp1) were also up-regulated with chromium treatment 
(Hussainzada et al., 2014). 
For TCDD, researchs have been conducted for the physiological role of 
Ahr in inflammation and autoimmunity using different animal models. Recently 
proposed paradigm has suggested that activation of Ahr (Aryl hydrocarbon 




 regulatory T 
cells (Tregs) and inhibits T helper (Th)-17, indicating that Ahr is an innovative 
therapeutic strategy for autoimmune inflammation. These promising findings 
generate a basis for future clinical practices in human (Hanieh, 2014). TCDD 
treatment suppresses the Th1 effector function by reducing IFN- production 
(Hanieh and Alzahrani, 2013; Singh et al., 2011b). The suppression may be 
attributed to the enhanced IL-10 that interrupts JAK-STAT pathway (Negishi et 
al., 2005). Another study showed that TCDD treatment could increase the 
recruitment of neutrophils in the lung following influenza virus infection in 
mice (Teske et al., 2008). However, there were other studies showing opposite 
trends. For example, Veiga-Parga et al. (Veiga-Parga et al., 2011) found that 
neutrophils and proinflammatory cytokines were reduced in the corneas of 
herpesvirus simplex-infected mice with TCDD treatment. In response 
to Streptococcus pneumoniaeinfection, there was a trend of decreased number 
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of phagocytes recovery in the lung lavage (Wang et al., 2012). Furthermore, 
TCDD treatment before pleuritis initiation reduced the number of neutrophils 
during inflammation (Calkosinski et al., 2013). Therefore, with all these studies 
together, it seems that the difference in TCDD administration time and/or dose 
contributed to the different trends of neutrophil response mentioned above. 
For E2, it has been shown that the female zebrafish exposed to the 
estrogenic stimulus (EE2) possessed granulomatous inflammation and 
proteinaceous fluid in the ovary, and the fish had also mineralized structures 
(Silva et al., 2012). For another tested endocrine disrupter BPA, there was 
another study using two established mouse models of allergic asthma to 
examine whether developmental exposure to BPA alters hallmarks of allergic 
lung inflammation. The results showed that in the mucosal sensitization model, 
female offspring that were maternally exposed to ≥ 50 μg BPA/kg/day 
displayed enhanced airway lymphocytic and lung inflammation, compared with 
offspring of control dams (Bauer et al., 2012).  
For the organic nitrogen compounds, a study with in vitro cell culture has 
shown that after NDEA treatment, modifications of cell cycle regulation and 
apoptosis pathways for nitrogen compound occurred. Additional modifications 
in gene groups and pathways of oxidative stress and inflammation have also 
been found, suggesting an increase in oxidative stress and proinflammatory 
immune response upon nitrosamine exposure (Hebels et al., 2009). Moreover, 
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such increase in inflammation could contribute to the carcinogenic process and 
play a part in organic nitrogen compounds exposure related cancers 
(Abdel-Hamid et al., 2012). 
The last tested category was organochlorine pesticides, such as lindane. 
Lindane is a known activator of neutrophil responses. Rebbapragada et al have 
studied about the biochemical pathways by which lindane stimulates 
neutrophil oxidant production and found phospholipase C as a direct target of 
lindane activation. Lindane stimulates an increase in phosphatidylinositol 
phosphate and induce oxidant production (Rebbapragada et al., 2005). In 
another study with rats, lindane has been found to have hepatotoxicity in a 
hyperthyroid state, comprising an enhancement in the oxidative stress status of 
the liver, which is largely dependent on Kupffer cell function and may involve 
generation of mediators leading to pro-oxidant and inflammatory processes 
(Simon-Giavarotti et al., 2002).  
Thus, all the environmental toxicants categories tested in this study yielded 
consistent results with previously published reports, except for TCDD. 
Different trends of inflammation response found by us and other may be due to 
different treatment stages or concentrations, as well as animals which may react 
differently to TCDD. All the other environmental toxicants from several 
different categories showed increase of neutrophils, including heavy metals (Hg, 
Cr, Cu, Cd, Zn and Pb), endocrine disrupters (E2 and BPA), organic nitrogen 
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compounds (4-nitrophenol and NDEA) and organochlorine pesticides (lindane). 
All these results together, indicate that this Tg(lysC:DsRed2) line is useful to 
test inflammation reaction caused by different environmental toxicants. 
Furthermore, this testing assay can be developed into rapid high-throughput 
inflammation screening assay by using the Imaris analysis.  
4.5 Real water sample test 
Previously, researchers conducted the real water sample tests mostly by in 
vitro cell culture, which means the total toxic effects of river water sample 
could be assessed by using a series of cell culture bioassays, based on specific 
modes of action. There was a study by a Korea group, in which the 
river water samples were collected and found to be polluted with a complex 
mixture of estrogenic and dioxin-like compounds. The methods they used was 
to detect the total estrogenic activity and CYP1A activity, which involved a 
combination of different in vitro bioassays with different mechanisms, 
including the estrogen receptor binding affinity test, E-screen assay, aromatase 
assay, and EROD assay. With all these tests together, the authors revealed a 
great deal of useful information regarding the potency and action modes of 
estrogenicity and antiestrogenicity inherent in the sampled river water (Oh et al., 
2006). 
There was another study about testing the inflammatory activity in 
river-water samples. The researchers assessed the potential immunological 
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effects of water sample in Germany. They found that all river-water samples 
triggered secretion of proinflammatory cytokines, such as TNF-alpha, IL-1beta, 
and IL-6, and free endotoxin was detected in all river-water samples. 
Furthermore, inhibition studies using the monoclonal anti-CD14 antibody 
biG14, which is known to suppress binding of lipopolysaccharide (LPS) to 
CD14 via binding CD14 itself, have revealed that free endotoxin is indeed the 
major inducer of proinflammatory cytokines in the river-water samples. To sum 
up, these results have suggested that the microorganism-derived endotoxin is a 
widely distributed contaminant in the tested aquatic environment (Wichmann et 
al., 2004).  
In our own tests, after screening the settled raw sewerage water from 
Singapore and secondary effluent water from USA, we demonstrated that the 
transgenic zebrafish lines could be applied for real water sample tests. As 
shown in the results parts, the real water sample may either affect the nervous 
system (shorter axon length) or affect the liver size or RFP intensity, which 
indicate the potential neurotoxicity or hepatotoxicity of the water sample to fish. 
Moreover, our testing method is based on in vivo system, which should reflect 
the real physiological situation better than traditional in vitro cell culture system 
mentioned above.  
Nowadays, with severe environmental contamination, it is of crucial 
importance that the real water sample contamination level should be monitored 
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routinely, in assessing ecosystem and protecting human health. Therefore, the 
fluorescent transgenic zebrafish testing system we developed could help reveal 
the in vivo effects of the contaminated water sample.  
Furthermore, as the real water sample contains mixture of vaious 
chemicals, we could further develop the multiple-chemical test system by using 
a combination of different fluorescent transgenic zebrafish, through which the 
addictive effects, synergistic effects, potentiation effects and antagonistic 
effects of chemical mixture could be studied. It is feasible to develop the test 
system into high-throughput screening assay and real-time biomonitoring of 
environmental water contamination assay. For more mechanistic studies to 
provide more detailed in vivo biological information, the zebrafish treated with 
real water samples can be used for further omic analyses, including genomics, 
transcriptomics, metabolomics and proteomics.   
4.6 Summery and future directions 
To develop an improved toxicological test using a fish model, we 
employed 9 transgenic zebrafish lines to investigate their potentials for 
monitoring toxicity of chemicals. We have tested a total of 24 chemicals with 
the 9 different transgenic lines. Finally, we found three useful transgenic lines to 
develop specific toxicity assays: (1) Tg(nkx2.2a:mEGFP) with GFP expression 
in the central nervous system (CNS) for neurotoxicity tests; (2) 
Tg(lfabp:dsRed;elaA:EGFP) (LiPan) with RFP expression in the liver and GFP 
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expression in the exocrine pancreas for hepatotoxicity tests; (3) 
Tg(lysC:DsRed2) with RFP expression in the neutrophils for inflammation 
tests.  
We tested 5 potential neurotoxins, 11 hepatotoxins and 12 inflammation 
positive chemicals. We found that the GFP-labeled ventral axons in 
Tg(nkx2.2a:mEGFP) fry were significantly shortened at concentrations that did 
not cause any detectable changes based on wild-type zebrafish. Similarly, for 
hepatotoxin analysis, the RFP-labeled liver showed significant changes in liver 
fluorescent intensity and/or liver size, with the corresponding changes of the 
endogenous fabp10a mRNA level. For inflammation reaction, the neutrophil 
number increased significantly after treatment of a variety of environmental 
chemicals. Thus, our study may open a new avenue to use the fluorescent 
transgenic zebrafish embryos/fry to develop sensitive and specific toxicological 
tests for different categories of chemicals. 
For using fluorescent transgenic embryos/fry in toxicological tests, the 
main challenger is how to analyze the GFP or RFP labeled images. Several 
softwares are available, such as ImageJ, Cell Profiler, Imaris, and Photoshop, 
etc. The total and average intensity of GFP or RFP images could be measured, 
and the length or size for different color labeled organs could be determined by 
these softwares. The main challenge would be how to catch good quality images 
and adjust the images to fit the softwares.  
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The limitation of current study is that the data of liver size is based on 2D 
images; if 3D visualization of liver RFP is performed, the sensitivity of 
detection is expected to be higher. However, 3D images and analyses are time- 
and cost-consuming, thus not suitable for rapid and high-throughput analyses. 
Moreover, research about other biomarkers of neurotoxins, hepatotoxins and 
inflammation might be needed to help validate the assay as the assay was only 
limited to phenotypical changes and did not yield enough information at genetic 
level, transcriptomic level or proteomic level. However, there are many 
available biomarkers which are inclusive in the chemical metabolism pathways, 
and many of them are supposed to be related to neurotoxicity, hepatotoxicity or 
inflammation, leading to a very complicated network and will need some 
bioinformatical inputs, which will be a promising area for future studies. 
As there are a large number of transgenic zebrafish available with 
fluorescent protein reporter gene expression in specific organs and tissues 
(Gong et al., 2001; Udvadia and Linney, 2003b), our study may open up a new 
avenue to test other useful fluorescent transgenic zebrafish for development of 
specific toxicological assays for different categories of chemicals. In particular, 
all the toxicological assays in fluorescent transgenic zebrafish can be 
accomplished within 5 days after fertilization, which is considered an in vivo 
test system alternative to adult animals, thus reducing the use of animals in 
toxicological tests.  
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Future development of current assays is the feasibility to develop it into a 
high throughput screening assay using imaging systems and computer 
algorithms that are already available (Kanungo et al., 2011b; Weger et al., 2013). 
For example, Kanungo et al have reported an automated high content screening 
method for in vivo measurement of axon length of zebrafish fry; the assay can 
be carried out in a 384-well plate format and fluorescent labels in axons is 
automatically captured and quantitatively analyzed (Kanungo et al., 2011a). 
Similarly, each embryo can be placed in individual well for simultaneous 
imaging and computerized analysis in high throughput setting. 
Moreover, these assays could be applied in the drug developing progress in 
future. In a critical review using data from ten biggest drug companies, it has 
been estimated that from 1991 to 2000 only 11% of drugs that entered clinical 
trials had been successfully brought to the market, and the two top causes of 
failure are the lack of efficacy and safety. One of the main underlying causes of 
such high attrition rate is believed to be a lack of reliable predictive preclinical 
toxicity studies, particularly in in vivo animal models (Kola and Landis, 2004). 
Currently, toxicity assay is heavily dependent on in vitro cell-based assays. 
There are major limitations in the cell-based toxicity assays, including lack of 
organ-specific toxicity mechanisms and limited use of pre-lethal indicators 
(Astashkina et al., 2012). While more cell-based in vitro assays have been 
developed in the past decade, development of in vivo models has lagged behind. 
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Rodent models such as mice, rat, guinea pigs and rabbit are often used and 
provide useful toxicology data, yet the high maintenance cost as well as long 
research time required to make them undesirable for large scale or high 
throughput studies. Besides, those models may either have relatively low 
occurrence of liver injury or require very stringent exposure conditions that may 
not be consistent to human (Roth, 2011).  
Sum up, to take all these factors into account, the in vivo transgenic 
zebrafish tests system may provide more promising feedback to human when 
compared with in vitro cell culture tests system; moreover, it is also a 
convenient and inexpensive tool for rapid in vivo tests of chemicals when 
compared with in vivo mammal system such as mouse, rat or rabbit. Therefore, 
the FT-DarT should be a useful high-throughput toxicity tests approach which 
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